Subject index to volume 106

SUBJECT INDEX TO VOLUME 106 A23187

calcium

interleukin

ionophore

platelet-activating Abdominal

AC-MBP(4-14)

1 and (rat), 106:1493 factor and, 106: 130 1

pain

eosinophilic

and, 106: l-

Addressin,

106:1042

Actin tine and (rat), 106:73 gelsolin and, 106:8 13-ss

ileal motility

indomethacin-induced

patterns and (rat), 106:649 hypothermic cardio-

pulmonary bypass and, 106:3 18 cells, microvilli

solute

in, raw kidney

Na+

Adaptive

106:125 of (rat), 106:423

lactate-anion exchanger and (rat), 106:559 Acetazolamide,

colon and, 106:125 Acetylcholine, N-Ace+

vector,

in gene therapy for

glucosamine,

crypt cell prolifera-

and, 106:827-tmig,

106:19 106:1436

and, 106: 1501

second screening flexible sigmoidoscopy superficial-type

hepatitis C virus and, 106: 1048 interferon (Y and, 106:558-tmig, Alaska,

106:557-tmig, crystallization fibroblast

biliary, as cholesterol promoter,

growth

factor

Adenosine Adenovirus, Adenylate

106:1254

Acid response,

106:1485

Adrenal

106:367

Saccharomyces 106:65

suppression,

lymphocyte response and, 106:1724-c misoprostol effects in cirrhosis and,

GI malignancies and,

106:1378-e

gastric, nitric oxide in (rat),

106:658 pancreatitis

glucocorticoid

pro-

Alcohol

drug and (rat), 106:405

pancreatic

contrast medium injury and (rat), 106:207

Adrenergic

and (rat), 106:1199

Adrenocorticotropic

hormone

and, 106:742,

dehydrogenase,

106:810-e

alcoholic liver dis-

ease and, 106:1085-srr

colonic relaxation

Aldehydes, Aldosterone,

and (dog), 106:606

insulin and (rat), 106:200 glutathione

blockade,

106:152

incomplete septal cirrhosis and, 106:459 liver and, 106:1085-srr

receptor,

molecules,

Alcohol fibrosis (baboon) and, 106:257-e,

in lipase cDNA transfer to gallcyclase

Adhesion

tinal injury and (rat), 106:346

anaphylaxis and (rat),

106:1505 rapid total paracentesis and, 106:558-tmig

(ATP), mucus and

boulardii and, 106:2,

hypoxia-induced intes-

and (rat), 106:960

food protein-induced

bladder, 106:1638

epithelial cell function and, metabolic,

monophosphate,

triphosphate

(rabbit),

106:231 (aFGF),

cholesterol gallstones and, 106:749 enterocolitis

3’5-cyclic

106:65

106:615

106:686

hepatitis B virus car-

Albumin

Saccharomycesboulardii and, 106:2,

bacterial overgrowth and,

cu,-Acid glycoprotein,

106:1436

Pz purinergic receptors and (rab-

Adenosine

106:1397-c

asymptomatic

riers and, 106:lOOO

colorectal,

bit), 106:1485

and,

aminotransferase

germander and (mouse), 106:285-tmig, 106:464

Adenosine,

106:794-srr

Acivicin,

colorectal,

and, 106:593

vasoactive intestinal polypeptide

Acidosis,

106: 1562 Alanine

Adenoma

106:875 perforations from upper endoscopy and,

Achlorhydria,

Alanine

bicarbonate transport and (rabbit),

flexible sigmoidoscopy inhibition

manganese in,

106:168

106:275-c

fecal occult blood testing and, 106:279-c

Achalasia deglutitive

106:1638

syndrome,

106: 1068-cr anoxic injury of hepatocytes and (rat),

superficial-type

tion and, 106:117

hepatitis C virus in-

106:1085-srr Alagille’s

Barrett’s esophagus and, 106:274-c,

patterns and

(rat), 106:649

Acini,

dietary lipids and

fibronectin receptors and (nude mice),

ileal motility

in enterocytes (rat,

fection in, 106:1072-cr

Adenocarcinoma

Na+ transport in proximal

in colon cancer,

Age, alcoholic liver disease and,

hyperplasia,

pancreatic insufficiency,

colonocyte metabolism

Bl-adducts,

Agammaglobulinemia,

(rat), 106:94

Acetate

chemotherapy,

human), 106:433

toxic oil syndrome and,

AdCMV.Lip

he-

and (rat),

106:899 Aflatoxin

sion, 106:1596

transport in proximal colon and,

Acidic

eicosanoid pro-

106:691

acid stilbene,

decarboxylase,

106:1024 Adjuvant

in hepatitis C virus transmis-

Acylanilides,

4-Acetamido-4’-isothiocyanatostilbene-

potassium

alcoholic liver

patocyte proliferation

duction and (dog), 106:297

alcoholic liver disease and,

2,2’-disulfonic

(ATP),

disease and, 106:1085-srr

enteropathy and

absorption,

Acupuncture,

106:1085-srr

triphospbate

S-Adenosylmethionine

(rat), 106:567 Active

beans and (rat), 106:73 Acetaldehyde,

Adenosine

S-Adenosyl-L-methionine,

pressures

Absorptive

in,

filaments, raw kidney beans in small intes-

intestinal,

mucosal, specific regulation of,

106:1122-ss channels and (rat), 106:1016

erosive esophagitis and, 106:108 Absorption,

syndrome

enteric cryptosporidiosis

prodrugs and (rat),

106:405

106:28

hepatic vein thrombosis and, 106:828Aboral

glucocorticoid

signaling and,

immunodeficiency

(AIDS),

tmig, 106:3 tmig,

cholecystokinin-

106:763 Acquired

gastroenteritis

protein,

coupled intracellular

(ACTH),

toxic oil syndrome and, 106:691 rapid total paracentesis and,

106:558-tmig, Alkaline

106:709

phosphatase

interferon ct and, 106:686 primary sclerosing cholangitis KEY

106:286-tmig,

TO ABBREVIATIONS

aga -

American

Gastroenterological

ciation

Asso-

e -

Editorials

Alkaline

rc -

Rapid Communications Selected Summaries

br -

Book Reviews

ss -

cr -

Case Reports

srr -

c -

Correspondence

vodd -

on Digestive

gastric, nitric oxide in

(rat), 106:367 Allergies

Special Reports and Reviews Viewpoints

response,

and,

106:494

Disease

mast cells and, 106:286-tmig tumor necrosis factor a and, 106:15 14

1744

SUBJECT

Allopurinol,

GASTROENTEROLOGY

INDEX

and (cat), 106:629

free radicals

American

Cancer

Society,

screening

ble sigmoidoscopy and, American

106:593,

primary

flexi-

scletosing

106:1-tmig,

recommendation

staphylococcal

Gastroenterological

Associa-

primary

Out new president-John M.D.,

H. Walsh,

acute colitis

and (tat),

cryptospotidiosis eicosanoid

106:1190

and (piglet),

production

Na+ transport

injury

and (rat), 106:168 acid

test,

plasma,

bacterial Antral

injury

and,

106:231

of hepatocytes

and (tat),

system

and,

106:973

A activity N, biliary,

106:755

acute pancreatitis Anaphylaxis,

and,

gastric

Apical

motility

Ancylostoma cuninum, enteritis

and,

eosinophilic

secretory

106:1-tmig,

alcoholic

trypsin

membrane

Barrett’s

adenocarcinoma

crypt-isolation

tehcnique

Angioarchitecture, tension

gastric, (tat),

Angiogenesis,

and,

106: 1589

and,

106:lOO

in portal

hypet-

bFGF-CS23

vascular

against

glycoprotein

and,

B core antigen,

hepatitis

B virus,

hepatitis

C virus,

106:1291,

106:231 106:823-c

106:243-ct 106:248-cr,

106:1048,

flow and

injury

and (rabbit),

entetocytes free radicals

and (rat),

primary

biliary

106:353

plasma,

gasttoentetitis

and,

106:1672-ct

cirrhosis

and,

106:193

cholangitis

diseases,

and, 106:1-

genetics

Autoimmune

hepatitis

genetics

of, 106:1676-stt

of,

TCR Cp in, 106:1321 type 2, hepatitis

C virus genome

in,

106:1603 nervous

system

gastrointestinal

disease and,

106:1114-e bowel disease and, 106:828-

tmig, Sandhoff

106:945 disease and,

106:1367-

Autonomic

106:775-ct

fatty acids and (tat), neuropathy,

in cirrhosis,

cisaptide

106:375 and,

Autoradiography cystic fibrosis

incomplete

septal cit-

familial

106:459

cirrhosis inhibition

and,

106:840

zone (AHPZ), and,

and,

106:95 1

histochemistry,

tin and,

and,

106:362 peanut

lec-

106:117

de-

106:827Bacteria

and,

106:828-

106: 1042 cirrhosis

and, 106:890

polypsosis

receptors

Avidin-biotin

106: 193

106:875

biliary

rectal mucosa

adenomatous

106:285-tmig,

106:827-tmig,

vein thrombosis

l-6:35,

esophageal overgrowth

and,

106:1284

tense, total tap for, 106:558-tmig, 106:709

and

106:185

Autoimmune

adherent,

primary

and (cat), 106:629

and, 106:285-tmig,

tmig,

and

and (opossum),

high-pressure

tmig,

106:49

sclerosing

somatostatin and,

hepatic

106:1554

primary

short-chain

treatment,

tmig,

pressure

106:916

platelets

106:859 106:1143

106:1603, biliary

inflammatory

vasopressin,

Artificial

and (tat),

106:3

primary

106:367

and,

sphincter

LKM-1,

Autonomic

Ascites

CD1 and (rat),

mucins

blood

pharmacology

glutitive

monoclonal CD18

mucosal

Arthritis

106:1596

5_hydroxytryptamine,

K+ chan-

106:1016

intestinal

thosis and,

Antibodies

106:606

anaphylaxis

106: 1676-stt

106:678 Arsenic

hepatitis

ulcerative

106:1382-e

ATP-sensitive

oxide synthase

106:2-tmig,

and,

Autoantibodies

vodd

(rat),

106:65 oi-acid

against

oxide and (tat),

Arginine and,

colon,

106:440

nutritional

inhibitor

and (dog),

eosinophilic

functional

nitric

in,

106:168 diarrhea

proximal

106:1444

106:637

cytoprotection

polypo-

(rat), 106:346

106:691

HLA-B27

106:557-tmig, glycine

and,

trypsin

relaxation

106:1-tmig,

106:336

Arginine

nitric

spondylitis,

gastric

(tat),

106:557-tmig,

(cat), 106:381

and,

Ancyfostoma caninum and,

Aprotinin,

and (tat),

toxic oil syndrome

Antibiotics,

food protein-induced

in, 106:125

106:1251,

hypoxia-induced

106:702

106:1106-tc Ankylosing

colonic

106:1542

vesicles,

nels and (tat),

Aneuploidy

prevents

(tat), 106:143

Atropine

106:1-tmig Aprikalim,

and,

secretory

postpran-

adenomatous

protects

colitis,

liver disease and,

106:1085-srt

pancreatic

and,

inhibitor

and (tat),

in familial

Appendicitis,

106:)

overgrowth

Australia, peptide

Appendectomy,

gastto-

(ANP),

liver damage

106:1505

Na+ transport

and (rat),

106:1505

Anesthetics,

motility,

and (ptai-

106:735

106: 1505

distention

endo-

106:2-tmig,

gastritis

food protein-induced

sis, 106:1404-tmig,

106:557-tmig

and,

106:615

and, 106: 108 1 -stt

and (tat),

and,

contractility

lower esophageal

APC gene,

percutaneous

peptide

ischemic

106:615

106:735

and (rat), 106:200

Anoxia,

index,

infections

106: 1662

natriuretic

Atrophic

and,

gene therapy

pancreatic

Amylase

Aniline,

overgrowth

spasmolytic

Aminopeptidase

Atrial

106:583

and (rat),

106:480

insulin

lO6:lOO6

Ancylo~toma cani-

Antrum

secretion

gallbladder rie dog),

hepatitis

106:1-tmig

dial, duodenal

106:168 esophageal

Aspirin,

woodchuck

Antropyloroduodenal

cY,-acid glycoprotein

esophageal

pneumonia,

bacterial

motility

due

106:13

hepatic

106:828-tmig,

anaphylaxis

acids

hepatic

Aspiration

106:678

therapy,

deficiency,

consumption

(ADH), and,

antibody,

num and,

106:488

anoxic

and,

cu,-Antitrypsin

of hepatocytes

liver failure

106:515-str

hormone

Antihelminthic

106:297

106:125

spp.,

No. 6

106:248-cr

scopic gastroscopy

virus and, 106:1418

and (dog),

and,

free, anoxic

Amino

Aspergdhs

B and

cholangitis

osmoteceptots Anti-HBC”

pulmonary,

to HCV and,

106:450

scletosing

Antidiuretic

106: 1139

Amiloride

Amino

Aspergillosis,

106:185

tion

Amines,

and,

106:185

enterotoxin

(mouse),

106:803-e

cholangitis

106:160,

Vol. 106,

enteritis, (rabbit),

and,

106:522-stt

of, hyperchlorhydria

106:557-tmig, Bacterial

106:255-e

infections

and,

106:615 Shiga-like

106:306,

toxin I in

106:540-e

June 1994

Balloon

SUBJECT INDEX

distension, ceptor

Barostat,

duodenal

stimulation

in colonic

mechanore-

Blood

relaxation

(dog),

Blood

106:1-tmig,

106:3

flow, gastric

mucosal,

106:606 Barrett’s

(rat),

adenocarcinoma,

pS3 mutations

Blood

esophagus

Blood

adenocarcinoma

and,

106:274,

cell cycle abnormalities continued Basic

and,

growth

factor

cell function

ulcer healing Basolateral

and,

by (rat),

Bombesin,

jejunal,

lactate106:559

and,

colon

mucin

carotene,

and,

alcoholic cystic

and,

liver disease and,

fibrosis

and,

of (rabbit),

lactate-anion

106:1388-ss

exchanger

biosynthesis,

maximal

in humans,

calcium

glycine

supplementation

and,

recurrence

hepatic,

in cholestatic

and,

metabolism, therapy,

pregnancy

short

and,

106:820-c

bowel syndrome

signaling,

Treatment, 106:550

taurocholate

obstruction,

HCV and,

liver failure

lectins

and,

mucin

synthesis

Bile salts,

ursodeoxycholic

oral, gallstone primary

angitis

and,

106:1-tmig,

tract,

surgery

incomplete

sclerosing

chol-

106:185

septal

cirrhosis

Breast

assay,

and,

cancer,

liver, liver failure

due to HCV and,

Budd-Chiari tmig,

lactose digesting

capacity

disease and-cr,

and,

106:1233

106:782

eicosanoid

releasing

106:248-cr,

106:994 and,

silent,

protease,

NaC transport

asymptomatic spp.,

and, 106:125

injury

of hepato-

hepatitis

B virus car-

106:lOOO

esophageal

infections

106:297

diffuse hemorrhagic

opathy

and,

and,

gastroenter-

106:500-cr

Capsaicin acute colitis

and (rabbit),

mucosal 106:286-tmig,

sensory and (dog),

anoxic

riers and,

106:828-

106:1042 production

peptide

106:1168

cytes and (rat), 106:168

gastric

106:42

syndrome,

intra-

106:763

106:512-srr

Bumetanide

Blacks

gastrin

C virus

~53 gene mutation

106:2-tmig,

106:248-cr

intake, and,

and,

hepatitis

and,

cholecystokinin-coupled and,

Capillaries,

DNA RNA

and,

irradiation

coprecipita-

in vivo gene transfer

signaling

Can&&

106:297 proton

with,

subjects,

cellular

and

106:1032 Branched

of, 106:551-br

106:459

Whipple’s

(dog), peak,

supplementation bypass

phosphate-DNA

Canada, production

flow and (rat), 106:440

106:1162

shock and (rat),

eicosanoid

(CGRP)

106:1208

106:951

blood

carbonate,

Calpain

hemorrhagic

recurrence Bragg

epithelium,

Bilirubin,

Calcium

and,

106:988

106:1-tmig

disease and, mucosal

Calorie of, cisapride

peptide

and (rabbit),

Calmodulin,

return

factors and, 106:1254

106:286-tmig,

Amyfostoma caninum

106:1-tmig

Bradykinin,

Bile salt therapy,

growth

gene-related

Calcium

106:924

acid and,

106:1333 and,

recombinant

in intestinal

obstruction,

BQ-123,

in, 106:389-tmig,

106:285

106:1077-srr

sounds,

106: 1349-srr 106:866

106:85

Textbook of Gastrointestinai Radiology,

pancreatitis,

106:270-ss

and (rat),

tion,

and,

and (rabbit),

factor and, 106:1301

Surgery of the Biliaty Tract, 106:551

Bowel

Bile reflux theory, of gallstone

receptors

acute colitis

Modern Nutrition in Health and Disease. 8th

due to

and (opossum),

in epithelium,

Calcitonin

106:1395

106:248-cr

106: 1162

Caco-2 colon cancer cells

Crohn’s

Bowel

and (rat), 106: 168

and,

platelet-activating

gastric

and,

106:1369-vodd

106:llSO bypass

iology, Pathophysiology,and Approach to

intestinal Tract, 106:27 1

106:134

sig-

106:1485

Normal and Disturbed Motility of the Gastro-

106:2 15

intracellular

106:763

oxide synthase

Liuw and Biliaty Diseases, 106: 172 1

liver disease,

and,

Pz purinergic

ed., 106:1721

gallstone

and (rat), 106:559

106:1444

in infants and Children, 106: 1126

carbonate

106:1190

of (rat), 106:423

cytoprotection

Management of Digestive and Livw Disorders

106:1162

106:399,

exchanger

naling

nitric

106:1126

106:273-c

herbal tea hepa-

Ca’+

Gastroenterology. 4th ed., 106:8 18

Experimental Studies to 1975,

and (rat), 106:559

and

106:464

metabolism

intestinal

History of Gastric Secretion and Digestion-

106:749 106:1562

Bile acids

Biopsy,

and,

HBV im-

agnosis, Management, 5th ed., 106:818

gallstones

ileal transport

Biliary

and (rat),

colonocyte

Gastrointestinal Pharmacothwapy, 106127 1

cholesterol

Biliary

hydroxyanisole,

E. coli and,

106:1374-e

Gastrointestinal Disease: Pathopbysiology,Di-

Bicarbonate

glutathione

106:1199

Butyrate

106:1137-tmig,

Gastrin, 106:550 by (rat),

106:1106-rc

Bile duct

106:2-tmig,

Diarrhea1 Diseases: A Review of Normal Phys-

rectal mucosa

ulcer healing

Butylated

ed., 106:1395

106:389

106:890

BFGF-CS23,

and,

Reviews

Clinical

synthetase,

lactate-anion

and,

and,

lower esopha-

transplantation,

munity

106:1085-srr Bethanechol,

cirrho-

Clinical Nutrition: Parentwal Nutrition. 2nd

106:125

Benzyl-GalNAc, Beta

in proximal

endoscopy

cholecystokinin-coupled

satiety

marrow,

adaptation Book

Na+ transport

106:557-tmig,

feeding,

106:1168, Bone

(rat), 106:94 Benzamil,

gastrostomy

upper

titis and (mouse),

106:13

in (rat), in mucosal

gas-

106:500-cr

sis, 106:1611

106: 1106-rc

Buthionine (rat),

in nonalcoholic

geal sphincter

membrane, dietary,

Bolus (bFGF)

injury,

colitis

composition,

106:1254

anion exchanger Beef tallow,

and,

for pancreatitis,

Body

106:1128-c

106:1128-c

fibrobast

epithelial

and,

P and

106:440

106:728

in, 106:553-c

surveillance

dysplasia

test,

275-c

substance

diffuse hemorrhagic

troenteropathy

Bursting

106:788-srr

106:286-tmig,

loss, chronic,

in, 106:1589 Barrett’s

Amylostoma caninum and,

eosinophila,

by, 106:583

1745

neurons

blood

106:1208

flow and (rat), 106:440

and (rat),

Captopril,

for liver cirrhosis,

Carbachol,

lower esophageal

sure and (cat), 106:381

106:1524 106: 113 1 -c sphincter

pres-

1746

SUBJECT

Carbohydrate

bacterial

GASTROENTEROLOGY

INDEX

microvillus

malabsorption

overgrowth

and,

Cat&se,

106:615 H2 nonproducers

and,

Carcinoembryonic normal

test, in colon cancer, Carcinogens,

alcoholic

precore

diarrhea,

5HT,

antagonist

Cardiogenic

shock,

heat shock gene expres-

Cardiopulminary

bypass,

ability

and,

Carotenoids,

intestinal

perme-

state,

CD4/CD8 CD18,

106:994 of hepatitis

tent infection hepatitis,

C virus for persis-

in patients

sysrem Whipple’s

relapse during

therapy

mission Cholestatic

hepatitis

in a patient

mitted

hepatitis

core region

to hepatic

of a mutation

in the pre-

of the hepatitis

B virus

infected

patient

with hexosaminidase

ciency (Sandhoff Diffuse

report

of a new entity,

106:500

high whole blood manganese in Alagille’s Hypervariable

syndrome,

region

(EZINSl) patient,

disease and,

recurrent

ing pregnancy

ulcerative

dur-

by pre-

colitis,

and secondary

somal autoantibody ing infection

with

106:506 liver/kidney

micro-

response

followC virus,

106:1672 jaundice

biliary

cir-

rhosis due to hyperthyroidism. intestinal

for

octapeptide

106:763

(CCK-8) test and, 106:488 and (prairie

contractility

dog),

106: 1662 Choledocholithiasis ultrasonography

and,

and,

106:742

choledocholithiasis

and,

106:1062 Cholelithoptysis, earlier

(rat), 106:207 intra-

report

of, 106:1400-c

toxin,

Saccharomyces boulardii and,

106:2-tmig,

106:763

106:65

liver failure

Cholestasis,

due to HCV and,

106:248-cr Cholestatic

liver

disease,

bile acid kinetics

in, 106:134 trials, and,

rectal epithelial 106:982 platelet

Cholesterol crystallization,

activation

106:840

a,-acid

glycoprotein

and,

106:23 1 gallbladder

contractility

and (prairie

dog),

106:1662 106:899

gallstone

lymphoma,

106:846

carcinoma, proliferation

106: 1032 and, 106:982

Children

recurrence

syndrome

as asymptomatic

protein

diffusion

ursodeoxycholic

in, 106: 1068-cr

hepatitis

B virus carriers,

Cholic

in, 106:1126-br in, 106:28

C virus in, 106:1672-cr

Chloramphenicol

bowel disease in, 106:1404106:1455 acetyltransferase

and,

Choline, Cholinergic

cholan-

recurrence

and, 106:2-

in proximal

colon

106:125 nicotinic

relaxation Cholinergic

106:1333

sclerosing

106:215

Na+ transport and,

106:749

106:494

acid, gallstone tmig,

disorders

106:2-tmig,

acid and, primary

gitis and,

106:1000 cryptosporidiosis

and,

106:215-tmig

Cholestyramine,

tmig, transplantation

106:1451 muscle,

amino acid consumption

Whipple’s disease,

and,

106:827-tmig,

inflammatory

106: 1342

106:1374-e, in gallbladder

Choledoscopy,

shock wave cavitation

for hepatocellular

hepatitis

106:2-tmig,

gallbladder

Cholera

for gastrointestinal

digestive

(dog),

106: 1062

106:782-cr

neutrophil,

and,

enteric in primary

signaling,

106:937

Chemotaxis,

Alagille’s

with hepatitis

(CNS),

cholecystokinin-coupled

rectal epithelial

in a patient

and (rat), 106:200 and,

Chemotherapy

106: 1668

Oral hairy leukoplakia

106:782-cr

for Whipple’s

Chemoprevention

and,

insulin

pancreatitis

signaling

and emptying

recurrence

Cholecystokinin

106:937

in acute pancreatitis

and,

in an

episodes

complicated

short-chain

106:782-cr Cerulein,

filling

satiety

106:553-c

and,

system

for colon cancer,

eclampsia,

Successful

nervous

proliferation

106:1072 Liver hemorrhage:

and,

disease, and,

Chemocytotoxicity,

C virus

agammaglobulinemic

Reversible

106:1708-e

and

levels

of hepatitis

distal,

shock wave cavitation

106:1068

envelope glycoprotein

Primary

~53 and,

cellular

basal ganglia,

gallstone

endoscopic

CGS9343B,

106:775

106: 17 18-ss (CCK)

in gallbladder

fatty acids and (rat), 106:375

esophagus

re-

106:215

in (rat), 106:35

Barrett’s

gastroenteropathy:

hyperintense

and (rabbit),

epithelium

for Whipple’s

gallstone

106:1-tmig

106:1652

Cell cycle

in a B defi-

disease),

hemorrhagic

Dystonia,

dexamethasone

Central

laparoscopic, and,

acute acalculous,

106:1554

stoma,

Cephalosporins, dysfunction

cholan-

fatty acids and (rat), 106:375

individual,

106:243 and autonomic

sclerosing

diarrhea

colonic

and,

Cholecystitis,

106:160

106:1242

Cefiuime,

with organ-transC virus infection,

in a chronically

normal

short-chain

106:782

106:248 The development

hepa-

Cecum

and re-

leading

failure

CD44,

disease:

with tri-

with cefixime,

protein, and (rat),

primary

Cecocutaneous

methoprim-sulfamethoxazole

Diarrhea

ratio,

inflammatory

with acute

106:1344

nervous

Cholecystectomy,

Cholecystokinin

106:1403-tmig,

Adaptation

Central

binding

gitis and,

Case Reports

choledocholithiasis

currence differentiation

sclerosing

106:160

106:1062

106:775-cr

106:1625

C virus RNA and,

1 and (rat),

primary and,

Cholangiography,

CCAAT/enhancer

liver disease and,

hepatitis

cholangitis

shock wave, in colon cancer,

tocyte

106:1093-srr Carrier

Cholangiocarcinoma,

106:937

106:318

alcoholic

106:1321

and,

disease and,

Cavitation,

106: 177

106:1514

interleukin

in HBV virus and,

hepatitis

mutation

Sandhoff

sion and (pig),

and (rat), 106:559

factor (Y and,

Chlorpheniramine,

106:243-cr

in,

106:1184

exchanger

necrosis 106:1493

autoimmune

liver disease and,

106:1085-srr Carcinoid

lactate-anion tumor

b, in acute pancreatitis,

Caucasians

106:546-ss

and,

Chloride

liver disease and,

106:1123-ss

and, 106:1242

toxic oil syndrome

No. 6

106:691

alcoholic

Cathepsin

(CEA)

epithelium

(CAT),

disease,

106: 1094-srr

106:1726-c

antigen

colonic

inclusion

106:771

106:557-tmig,

Vol. 106,

responses,

sphincter

transmitters,

and (dog),

colonic

106:606

in lower esophageal

(cat), 106:381

SUBJECT INDEX 1747

June 1994

Chromosome

17p

Barrett’s

carcinoembryonic

adenocarcinoma

colon cancer and, Cimetidine,

and,

106: 1589

106:42

bFGF-CS23

and (rat),

106: 1106-m Circadian

eration Circulatory

rectal epithelial

and,

prolif-

technique in, 106:883

sis, 106:558-tmig, dysmotility

tmig,

106:827-

and,

oncogene,

fibronectin

106:924

and, 106:268-

in pancreatic

carcinoma,

overview

of,

106:818-br

parenteral

nutrition

Clofibrate,

herbal

and,

106:1395-br

linkage

and,

height,

weight,

and risk of,

tea hepatitis

as marker

106:353,

and (mouse),

dilyicile,

mucosal

barrier

and,

colitis,

chavomyces boulardii and,

Sac-

106:2-tmig,

herbal

(mouse),

tea hepatitis 1 (CDl)

expression

of (rat),

acute stress reactions

mole-

familial

and,

and,

106:1403-

of by PCR,

glucose

adenomatous

gallstone

recurrence

106:1-tmig

Na+ and SCFA malabsorption

in (rat),

in (rabbit),

blood

liver disease and, attachment

to ECM and (rat),

colonic

epithelium

phosphatidylcholine 106:152, platelet

and,

and (baboon),

106:257

activation

and,

peanut

normal

and,

isolation

method,

and (rat),

(dog),

neurons

chemotherapy

in, 106:899

Comfrey,

rates in ulcerative programs,

fatty acids and (rat), 106:375,

esophagus: 106:275

physiology

predict

anat-

in Barrett’s

insights,

Correction,

106:824

Detection

of colorectal blood

gold standard

titis,

esoph-

106:553

adenomas

tests,

by fecal

106:279 for chronic

hepa-

106:1723 of bile acid metabolism by pregnancy?, Barrett’s: report

un-

106:820

is continued

lance appropriate?,

106:1208

colitis

106:278

in Barrett’s

agus: further

An earlier

surveil-

106: 1128

of cholelithoptysis,

106:1400 Endoscopic

ultrasonography

sis of hypertrophic

in the diagnogastropathy,

106:820 adenomatous

106:285-tmig, targeting,

without

gastropathy,

106:1132

Dysplastic

1 and (rat),

in (rabbit),

flexible sigmoidoscopy

cancer

omy?,

masked

106:775-cr

response

106:1724

activity

mortality

Diagnostic

106:423 familial

lymphocyte

by alcohol,

106:1726

Disorder

interleukin

106: 1024

Colon adjuvant

and,

in, 106:125

by ileal distension

short-chain

hepatocyte

impaired

is caused

Cell cycle abnormalities

in, lob:117

Colonoscopy

perfusion

Alcoholics’

occult

disease and,

and,

106:1242 Collagenase

lectin

106: 1493

106:691

colonic epithelium

and, 106: l-

106:185

laser coagulation

Sandhoff

sensory

toxic oil syndrome CoIIagenase,

cholangitis

secretion, 106:827-tmig,

106:840

and,

Correspondence

Can esophageal

106:606

lO6:1242

106:259

diacylglycerols

Cancer surveillance

and,

in, 106:117

Na+ transport relaxation,

106:473 normal

testing

106: 544-ss

106:1096-srr

tomogra-

what is the end point?,

endoscopic

Collagen

dietary,

and,

in acute pancre-

and (rat), 106:207,

bran,

diarrhea,

proximal

106:1208

injury

NSAIDrelated

in carcinoid

106:160,

proliferation,

neurons

bowel syndrome

computed

surveillance

sclerosing

tmig,

106:1190

hepatocyte

Contrast-enhanced

Cancer

lectin

primary

106:1727-c

raw and

106:945

Anti-inflammatory 106:423

response,

peanut

alcoholic

and (dog),

106:277-c

Colitis microscopic,

production

in (rat),

polyps fecal occult

and,

106:42

in, 106:1436

106:1184

polypsosis

irritable

106:828-tmig,

Corn

106:85

microscopy,

106:73

atitis and,

106:2-tmig,

tumors

eicosanoid

hypertonic

106:362

biliary,

sensory

and,

106:297

106: 1143

106:1477

Colectomy,

distal,

scanning

106:883

superficial-type

of differentiation

tmig,

106:42

cavitation

as,

beans in small intestine

(rat),

for, 106:803-e

shock wave-induced staging

and

106:464

laser

phy (CECT),

screening

106:65

cule,

proliferation

aminopeptidase

in colon cancer cells and,

Constipation,

and, 106:2-tmig,

liver failure

106:248-cr

A (Con A) protein,

kidney

106:937

Clotrimatole, Cluster

lectins

106:982

difjicile-associated

(CT) choledocholi-

106:1062

106:755

for, 106:285-tmig,

rectal epithelial

106:257-e Clostridium

106:815-ss

106:389

p53 mutations

106:464 Clostridium

binding

Confocal

mucin

and,

Concanavalin

for, 106:1081-srr

in, 106:85

of, 106:554-c

tomography

due to HCV and,

106: 1263

lectins

polypeptide,

definition

Computed

in, 106:lOO

106:1121-ss

in, 106: 1365~vodd

106:336

intestinal

106:1467

and (nude mice),

genetic

nutrition

advances

and,

106:1312

peptide,

vasoactive

thiasis

gene therapy

gastroenterology,

Clinical

gastrin

(cDNA)

106: 1143

synthetase,

Compliance, receptors

of hepati-

106:1638

106:279-ss,

flow cytometry

106:1645 Clinical

lipase,

106:19

ileus and,

DNA

spasmolytic

ss, 106:277-ss,

106:916

postoperative c-Ki-rus

and,

Complementary glutamine

polypsosis

106:277-c

neuropathic

Colic,

adenomatous

fecal occult blood testing

106:709

infection, 106:1596

CD1 molecule,

fiber in, 106:883

familial

Cisapride

Cold,

in, 106: 100

106:1542

of rapid total paracente-

Community-acquired tis C virus,

diacylglycerols

106:982

effects,

test in,

crypt-isolation dietary

rhythms,

antigen

106:546-ss

polypsosis

and,

106:362 and,

blood testing

tect colonic 106: 150 1

106:1702-e in liver disease-tmig,

Fecal occult Fentanyl

and the wooden

“H, nonproducers” 106:285

polyps,

carbohydrate,

will fail to de106:277 chest,

106:820

and malabsorption 106:1726

of

1746

SUBJECT

GASTROENTEROLOGY

INDEX

Helicobacterpylori and gastric cancer: limitations of retrospective

studies,

polymeric enteral diets and, 106:1393-ss primary sclerosing cholangitis

106:1398 anti-HBc,

Cytochrome

quality of life index for, 106:286-tmig,

106823

Hypercoagulability

106:287

in inflammatory bowel

P4503A

Cytofluorimetry,

106:643,

hepatitis C virus

106:807-e

inhibitor,

for herbal

tea hepatitis (mouse), 106:464

smoking and recurrence in, 106:558-tmig,

disease, 106:281

P450IID6,

No. 6

and, 106:1603

106:1-tmig

HIV infection and isolated detection of

Cytochrome

and,

Vol. 106,

shock wave cavitation and,

106:937 Cytokeratin,

in GI malignancies,

106:1326

Is Barrett’s guilty as charged?, 106:274

somatostain receptors and, 106:95 1

Is there an editorial trade embargo on sci-

substance P and, 106:828

alcoholic liver disease and, 106: 1085-srr

tumor necrosis factor (Y and, 106:1455

enterocolitis

entific imports?,

106821

Is vasoactive intestinal polypeptide a key

Crohn’s

neuropeptide in achalasia?, 106: 1397 Low-dose captopril for patients with liver

disease activity

psychological

106: 5 3 3-vodd

stress and,

staphylococcal enterotoxin B and (mouse),

in chronic liver diseases,

ulcerative colitis and, 106:557-tmig, 106:637

106:1291

Crohn’s disease, 106:553 colitis: a “transatlantic”

uni-

fying concept, 106:1727 Possible immunopathogenesis cholestatic

hepatitis,

for fibrosing

106822

Progression of primary biliary cirrhosis on ursodeoxycholic acid, 106:555 Prostaglandin

Ez may be a nonadrenergic

noncholinergic

transmitter

in the

lower esophageal sphincter, 106:1397 The safety of omeprazole: true or false?, 106: 1400 Serum hyaluronan and changes in sinusoidal perfusion, 106:280 Somatostatin-receptor

scintigraphy

in en-

docrine tumors, 106:1723 Surveillance for ulcerative colitis does not and cannot work, 106:1129 What constitutes Corticosterone,

compliance?,

glucocorticoid

106:554

prodrugs and

(rat), 106:405 Corticotropin-releasing

factor

Corticotropin-releasing

hormone

in enterochromaffin

(CRH),

cells, 106:827-

tmig, 106:859

and, 106:1638

peanut lectin and, lob:117 transferrin endocytosis and (rat), 106:414 technique,

and, 106:252-e

of (calf, human), 106:28 axis

Cs+, Na+ transport in proximal colon and, 106:125 breath test, He~icobacterpyloriand, 106:1263 monophosphate,

eico-

sanoid production and (dog), 106:297 Cycloheximide,

toxic oil syndrome and,

106:691 Cyclooxygenase

inhibition,

indomethacin-

induced enteropathy and (rat), 106:567

allergy, tumor necrosis factor (Y and, necrotizing enterocolitis

and (piglet),

Cox model analysis, multivariate,

colon can-

for Crohn’s disease, 106:287

enzymes,

aflatoxin B 1 -adduct for-

mation and (rat, human), 106:433

and (piglet), Cysteine

106:1215 rapid total paracentesis and,

and (rat), 106: 1199

Cystic fibrosis

disease and, 106: 1368-vodd

parenteral nutrition

and, 106: 1368-vodd

gene therapy and, 106:1080-srr rectal mucosa in, protein phosphorylation

peanut lectin and, 106:117 platelets in, 106:827-tmig,

exocrine pancreatic insufficiency and, 106:1638

mesalazine for, 106:553-c

106:840

failing, 106:827-

106:875 gradient

gel electrophoresis,

acid, gallstone recurrence and,

106:2-tmig,

106:215

Deoxyribonuclease,

normal colonic epithe-

hum and, 106:1242 Dexamethasone aflatoxin Bl-adduct

formation and (rat,

human), 106:433 glucocorticoid

prodrugs and (rat), 106:405

herbal tea hepatitis and (mouse), 106:464 intestinal permeability

and (rat), 106:35

Diacylglycerol cholecystokinin-coupled

intracellular

sig-

naling and, 106:763

106:1184

ctyptosporidal,

enterotoxicity

and, 106:890

and (calf,

human), 106:28 E. coli strain RDEC-H19A 106:306,

in (rabbit),

106:540-e

food protein-induced

alcoholic liver disease and, 106:1095-srr glutathione

106:558-tmig

inhibition,

Deoxycholic

catcinoid, 106:1429

tumor necrosis factor (Y and, 10631455 CYP3A

cer staging and, 106:42 “Cr, necrotizing enterocolitis

Deglutitive

Diarrhea

enemas, for ulcerative colitis,

106:1215

glyco-

colon cancer and, 106:883

Cyclosporine

106:1514

enzymatic, a,-acid

protein and, 106:231

colon cancer staging and, 106:42

106:1562

adenosine

106:1645

Denaturing

laminin A-chain isoforms and, 106:829

5’Cyclic

DCC gene, in pancreatic carcinoma,

tmig,

bicarbonate transport and (rabbit),

{i4Qurea

glycine and (rat), 106: 168

Deglycosylation,

106:1418

Cryptosporidium pawurn, enterotoxic effect Crypt-villus

cellular, hepatitis B virus and,

lob:664 Cytoprotection,

metric analysis, 106:lOO

and (piglet),

Cytoplasm,

for flow cyto-

Cryptosporidiosis complexity of intestinal pathophysiology

Cow’s milk

enteral nutrition

immediate early promoter, lipase cDNA

106:362

Crypt-isolation

(CMV)

esophageal infections and, 106:5 17-srr

familial adenomatous polypsosis and,

(CRP), gas-

tric emptying and (rat), 106:1568

Cytomegalovirus

Crypt cells

glutamine

and (rat), 106:960

inflammation and,

106:450

Cryoglobulinemia,

106:273

Crohn’s

intestinal

106:1477

Mesalazine as maintenance treatment in

Creatinine,

index (CDAI),

quality of life and, 106:287 Crural diaphram,

cirrhosis: what is low?, 106:1131 Maximal bile acid biosynthesis in humans,

Microscopic

Cytokines

anaphylaxis and (rat),

106:1505 L-glutamine and, 106:1698-e infectious pathophysiology

of, 106:1705-e

Saccharomycesboulardii and, 106:2-rmig, 106:65 inflammatory, E. coli in, 106:1403-tmig, 106:1554

SUBJECT INDEX 1749

June 1994

irritable

bowel syndrome

tmig,

and,

106:828-

hepatic

106:945

microvillus

inclusion

disease and,

disease and,

106:775-cr

titis C virus and,

hepa-

106:1072-cr

in, 106:433

and,

106:1369-

Diffuse

spasm,

deglutitive

and, 106:827-tmig,

hemorrhagic

in-

106:875

juice creatitis,

and (rat),

hepatocyte

proliferation

106:49 and (rat),

and children,

of lecrins,

106:85 method,

by (rat), 106:473

4,4’-Di-isothiocyanatostilbene-2,2’disulfonic

acid,

proximal

Dimethylsulfoxide rus and,

in

response

growth

to,

Hepatitis

ulcers,

in cirrho106:258

(DMSO),

hepatitis

B vi-

Is there a relationship cohol-

disease and, and, 106: 1137-

stricture

disease,

~53: tumor

Disodium

technique

cromoglycate, duced

and,

106:1589

and,

lO6:lOO

Recurrence

EZ/NSl

and (rat),

misoprostol

fluctuation, eration

and,

and,

106:658

rectal epithelial

E2INSl

region,

Eating

106:982

B virus,

106:664,

proliferation

106:1048

and (rat),

jejeunoileal

resection

DNA

index,

DNA

polymerase,

and (rat),

colon cancer and, hepatitis

106:94 106:lOO

B virus and,

sequencing,

direct,

colon cancer stag-

ing and, 106:42 Doparnine,

Sandhoff

disease and,

106:775-cr Doppler

of gallstones

ultraaonography

Regulatory Smoking: Targeting

releasing

and,

106:3

EDTA,

barrier?,

breaching

Elderly,

and gastrointestinal

malignancies, 106: 1378 Appendectomy and ulcerative colitis: what connection?, lar carcinoma,

106:264

intestine,

hepatocellu-

106:1376

106:807 106:1702 portosystemic

embargo,

106:1384

on scientific

im-

106:821-c

necrotizing

enterocolitis

colonocyte

and (piglet),

field duced (rat),

differentiation

and

106:297

bacterial

Electrical

Electrolytes,

106:1382

An assay for micrometastatic

106:262

a note of caution,

(dog),

the mucosal

106:255

molecules

nonsur-

of the lactase ac-

intrahepatic

trade

Eicosanoids, bacteria:

fi-

106:1215

106:306

Editorials

following

colonoscopy,

ports,

Edema

Adherent

in adult

shunts:

peptide Editorial

(rabbit),

hepatic

lithotripsy,

bowel disease?,

C virus and,

106:1168

Ancylostoma c&mm

of

good or bad for inflammatory

Transjugular gastrin

control

with extracorporeal

mechanisms

tivity

106:185 in agam-

106:1072-cr

hepatitis

behavior,

Adhesion

106:664

and,

glycoprotein,

E. coli enteritis

106:1024

primary

106: 1344-cr

prolif-

and,

hepatocyte

cholangitis

envelope

DNA hepatitis

antibody,

maglobulinemia,

action,

Diurnal

monoclonal sclerosing

food protein-in-

anaphylaxis

106:1505 Diuretic

DNA

of alcohol-induced

shock-wave 7Ei2Hi2

through

106:1708

106:257

syndrome,

106: 1068-cr

adenocarcinoma

of

brosis by phosphatidylcholine,

106:1589

in Alagille’s

of alpancre-

106:1705

suppression

Prevention

and,

hypertri-

for the pathophysiology diarrhea,

the cell cycle, esophagus

between

and development

gical therapy

crypt-isolation

the corner

106:SlO

infectious

Diploidy Barrett’s

for diarrhea,

or gallstone-induced

New paradigms

106:1174

Barrett’s

Dystonia,

absorppathobi-

C virus pathogenicity:

atitis?,

106:1128-c,

106:664

and therapy

glyceridemia

in peptic

Dysplasia,

sodium

106:1118

basic fi-

106:907

106:152,

insuf-

106: 17 11 in intestinal

ology,

factor and (rat),

Helicobacterpyhri

Dysphagia,

106:125

Dilinoleoylphosphatidylcholine, sis (baboon),

motor

Sandhoff

tmig,

Na+ transport

colon and,

for exocrine pancreatic

[ion: lessons for physiology,

106:775-cr Dyspepsia,

and satiety,

106:1698

of, 106:797-cr

Dysautonomia, perfusion

a way

pieces of the jigsaw puzzle are found,

broblast

isolation

system:

peptide

r-Glutamine

106:215

106:1106-rc

Digitonin-collagenase hepatocyte

and,

gastroenteropathy

pyyloric

perforation

of, 106:1126-br 106:1233

test and, 106:488

106:540 disease and the

106:1374 Gene therapy

recurrence

an appropriate

at last?,

106:1114

Gastrin-releasing in acute pan-

106:1390-ss

with Shiga-like

nervous

ahead?,

of intes-

106:252

gastrointestinal

autonomic filaments

106:583

106: 1126-br

the complexity

model

Functional

106:500-cr

distention,

of lactose,

dexa-

106:35

intermediate

hemorrhagic

and,

106:259

associated

ficiency,

diffuse

Digestion

history

flux analysis,

total protein,

tomography

toxin productioncollin animal

and (rat),

bile, gallstone

106:1024 in infants

Enterocolitis

liver dis-

106:1085-srr

amino acid consumption

enterocytes

106: 132 1

Duodenum

cu-Difluoromethylornithine

disorders,

and,

efficacy,

is it beneficial

tinal pathophysiology,

in, 106:1326

gastroenteropathy,

of, 106:500-ct

computed

or harmful?,

and (rat),

used, alcoholic

carcinomas,

Duodenal

beyond

106:803

106:1493

hepatitis

commonly

Ductal

overview

1 and (rat),

methasone

vodd esophageal

anaphylaxis

Dual sodium-mannitol

short bowel syndrome

hibition

and,

Cryptosporidiosis:

ease and,

in (rat), 106:94

Diffuse

synthetase

dis-

106: 1112

Contrast-enhanced

autoimmune

Drugs,

in, 106:85

lipids

kinesia,

106:1505 DR4,

aflatoxins

of motility

the perils (and pearls) of pto-

in acute pancreatitis:

interleukin

Diet lectins

glutamine

food protein-induced reaction,

pharmacology

Colon cancer screening:

Doxantrazole

tmig termination

The clinical

106: 1138-tmig,

106:1312

mast cells in, 106:286-

chain

106:828-

orders:

and,

Dot blot analysis,

of, 106:550-br

toxin-mediated, Dideoxy

and,

106:1277

Sandhoff

overview

obstruction

106:1042

TIPS placement

106:771-cr motor,

venous

tmig,

overgrowth stimulation,

ion transport 106:286-rmig, radiation-induced

dysfunction 106:324

in, 106:615 radiation-indysfunction

and

106:324 ion transport

and (rat), 106:286-tmig,

1750

GASTROENTEROLOGY Vol. 106, No. 6

SUBJECT INDEX

activity, psychological

Electromyographic

stress and, 106:1477 Electron

microscopy

insulin and (rat), 106:49

mucosal barrier and, 106:255-e

lactate-anion exchanger and (rat), 106:559

signal transduction

radiation-induced

toxins, Saccbaromyresbosdardii and, 106:2-

ion transport dysfunc-

E. coli and, 106: 1150

tion and (rat), 106:286-tmig,

ileal motility patterns and (rat), 106:649

106:324

Electrophoresis,

lectins in colon cancer cells

Emptying,

Enteroglucagon, Enteropathy,

lfi and (rat), 106:1568

tumors,

scintigraphy Endogenous

polymerase

assay, hepatitis B

Envelope

for radiation-in-

retrograde retrograde

and, 106:1062 cholangiopancrea-

glycoprotein,

in agammaglobuli-

amylase and, 106:557-rmig,

assay

cholesterol gallstones and, 106:749 and, 106:1405

Helicobactwpyhi

primary sclerosing cholangitis

primary sclerosing cholangitis

choledocholithiasis

secretion, acid and pepsin effects on,

and,

106:576

hypertrophic gastropathy and, 106:820-c

Enzymes, Eosinophilic

cyclosporine enemas and, 106:1429

insulin and (rat),

gastroenteritis,

dog tapeworm

06:3

acute colitis and (rat), 106:1190 bicarbonate transport and (rabbit),

1 (ET-I),

and, 106: 500-cr hemorrhagic shock

intestinal permeability

and,

cyclosporine,

Energy balance,

alcoholic liver disease and,

system,

ileal motility pat-

terns and (rat), 106:649 Enteritis,

eosinophilic,

Enterochromaffin

inducers,

microsomal,

106:1-tmig,

106:827-tmig,

106:3

lower esophageal sphincter

Escherichia

coli

formation and (rat,

inflammatory diarrhea and, 106:1403-

human), 106:433

106:362

vari-

106:1542 for peptic stricture disease, 106:907 phase III activity and (dog), 106:1533 Far East, asymptomatic hepatitis B virus car-

enteritis,

Shiga-like

106:306,

polyposis

Famotidine

bacterial adherence and (rat), 106:35

106:859

Enterocytes aflatoxin Bl-adduct

virus (EBV), esophageal infec-

function and (cat), 106:624

cells, neuropeptides and,

adenomatous

sulindac for, 106:285-tmig,

able expression of, 106:1404-tmig,

tions and, 106:520-srr Erythromycin,

XIII,

in colitis (rat), 106:399 Familial

106:464 Epstein-Barr

106:13

tumor necrosis factor (Y and, 106:1455 nervous

hydrolase

herbal tea hepatitis and (mouse),

percutaneous endoscopic gastroscopy and,

(rat), 106:73 Factor

transferrin endocytosis and (rat), 106:414 Epoxide

inclusion disease and,

106:7Jl-cr

Enteric

raw kidney beans in small intestine and

Saccbaromycesboulardii and, 106:2-tmig, 106:65

106:2-tmig,

106:4J3

F-actin,

E. coli and, 106:1150

106:1429

nutrition

microvillus

(nude mice), lob:19

colorectal crypt and, 106:982

106:1094-srr Enteral

perivenous hepatocyte attachment to (rat),

cytokines and, 106:534-vodd

106:35 Enemas,

106:19

cells, intestinal

a#,-positive

matrix

fibronectin receptors and (nude mice),

CD1 molecule and (rat), lob:1143

and (rat), 106:988 Endotoxin,

Extracellular

106:1562 Epithelial

system A activity impairment

by (rat), 106:480

upper, perforations by, 106:787-srr cells, diffuse hemorrhagic gas-

and, 106:J42

portal hypertension and (rat), 106:702 short-term,

erosive esophagitis and, 106:108

Endothelin

and (rat), 106:473

Epinephrine

and, 106:500-cr

troenteropathy

liver and, 106:1085-srr

pancreatitis

in, 106:1-tmig,

diffuse hemorrhagic gastroenteropathy

Ethanol

long-term, hepatocyte attachment to ECM

microvillous,

106:49

Endoscopy

tumor necrosis factor (Y and, 106:1455

fibrosis and (baboon), 106:152106:257-e

vasoactive intestinal polypeptide and,

and, 106:1062

106:973

106:728

106:185

ultrasonography

physiology, anatomy and, 106: 1132-c

Esterase,

PAP protein and, 106:55J-tmig,

and,

and,

106:875

106:1444

receptors and (rabbit),

106: 1485

106:494

disorders, inhibition

106:827-tmig,

perforation of, 106:787-srr

liver failure due to HCV and, 106:248-cr 106:286-tmig,

Sandhoff disease and,

nitric oxide synthase in (opossum),

106:3

106:728

and,

infections, overview of, 106:509-srr motility

immunosorbent

P, purinergic

tography

immunsuppression

106:775-cr

(ELISA)

cholangiography,

choledocholithiasis

Endothelial

dysmotility,

Ancylostoma caninum and, 106:1-tmig,

106:544-ss

Endoscopic

tumor-derived 106:1717-ss

short-chain fatty acids and

Enzyme-linked

duced mucosal hemorrhage,

Endoscopic

diarrhea and

nemia, 106:1072-cr

laser therapy,

cancer

(rat), 106:375

virus and, 106:664

Endoscopic

(rat),

p53 mutations in, 106:1589 cryptosporidial

Enterotrophism,

in, 106:1723-c

transferrin (rat), 106:414

medical healing of, 106:907 Esophagus

(calf, human), 106:28

receptor

Endocytosis,

Endoscopic

erosive, esophageal clearance in, 106:108

resection and

indomethacin-induced

Enterotoxicity, somatostatin

Esophagitis

106:567

primary biliary cirrhosis

and, 106:1284 Endocrine

jejeunoileal

(rat), 106:94

duodenal distension and, 106:583 interleukin

and (cat), 106:381

in transposed

small bowel (rat), 106:1576

gastric

anaphylaxis and (rat), 106:1505

Encephalopathy,

adaptation,

106:65

lower esophageal sphincter pressure

taurocholate and (rat), 106:866 Enteroendocrine

and, 106:85

tmig, Eserine,

and, 106: 1150

toxin I in (rabbit),

106:540-e

tmig, 106:1554

riers and, 106:lOOO Fasting cholestatic

liver disease and, 106:134

duodenal distension and, 106:583 pancreatitis

and, 106:742

June 1994

SUBJECT INDEX 1751

Fat, dietary

Forskolin

bacterial overgrowth and, 106:557-tmig,

Saccharomycesboulardii and, 106:2-tmig,

106:615

106:65

colon cancer and, 106883 Fat-storing

France,

cells

liver, platelet-activating

factor and,

106:285-tmig, Free radicals,

blood testing,

and, 106:268+s,

colon cancer

Fungal

diffuse hemorrhagic gastroenteropaindomethacin-induced

enterop-

esophageal infections

growth

factors

neo-clerodane

diterpenoids,

ger-

Furosemide

Galactosamine,

colon cancer and (nude mice), 106:19 hepatitis,

immuno-

106:152,

and,

overview of-br, 106:818 Gastrointestinal Gastroparesis, Gastropathy, Gastrospirilum

inflammatory bowel disease and, 106:596 Fluid ingestion,

106:185 and, 106:269-ss,

oxygenated, ileal motility

Gamma

camera

imaging,

glutamyl

sion, 106:1596 Food allergy, Ancyfostoma caninum and, 106:3

Gastric Gastric

permeability

(fMLP),

Gastric

pouch 106:1533

heat-shock,

106: 177

lactase, 106:1223

and (rat),

mucin, 106:285-tmig,

and (rat),

106:353,

106:1054

~53, 106:1403-tmig anaphylaxis and

pancreatic carcinoma and, 1O6:1645 primary sclerosing cholangitis and, 106:1-

cells, PL purinergic

tors and (rabbit), intestinal

106:42 familial adenomatous polyposis and, 106:1404-tmig, 106:1542

Lynch syndrome and, 106:815+s

cells, glutathione

mucous

colon cancer staging and, 106%tmig,

hepatitis C virus, 106: 1603

(rat), 106:1505 Gastric

and, 106:35

platelet-activating

106:1199 Gastric motor response,

N-Formyl-methionyl-leucylphenylalanine

inter-

106:1106-rc

anaphylaxis induced by (rat),

106:1505

abdominal, in

transpeptidase,

acid, bFGF-CS23

106:239

alcoholic liver disease and, 106:1085-srr

factor and, 106: 1301

shock wave cavitation and, 106:937 acid, in adjuvant therapy for colon

albumin mRNA,

liver disease, 106: 134

Gas chromatography,

cancer, 106:899 Folk remedies, in hepatitis C virus transmis-

106:215,

feron a! and, 106:686

in adjuvant therapy for colon cancer, 106:899

Genes

106:262-e

cholestatic Gamma

(5-FU)

and,

106:145 1 ulcerative colitis and, 106:125 1

recurrence of, 106:1-tmig,

patterns and (rat), 106:649

106:1405

overview of, 106:813-ss

alcoholic liver disease and, 106:1085-srr

106:742,

106:810-e

106:225,

Fluorocarbon,

Gelsolin,

106: 1726-c

gastric infection

colon cancer and, 106:883

protein diffusion into, 106:749

cholesterol gallstones and,

hominis,

satiety effects of cholecystokinin

pancreatitis

106:749

NSAID-related,

Gender

Gallstones

gastrin releasing peptide

and, 106:1168

gastric emptying and (rat),

with (monkey),

intact, sphincter of Oddi dysfunction and, 106:1716-ss

technique and, lO6:lOO

normal and disof, 106:271-br

106:1505

filling and emptying (dog), 106:1652

tmig,

tract,

turbed motility

primary sclerosing cholangitis and, lO6:1-

crypt-isolation

Food protein,

signaling and, 106:763

aspirin and (prairie dog),

gallstone recurrence and, 106:215,

Barrett’s adenocarcinoma and, lO6:1589

5-Fluororacil

106:1114-e

106:1638

cisapride and, 106:924

diseases

gene therapy for, 106:1076-srr

106:225

Flow cytometry

Fluorescein,

106:117

exocrine pancreatic insufficiency and,

106:185 toxic oil syndrome and, 106:691

vasactive in-

autonomic nervous system and,

106: 1662

106:257-e

sphincter,

106:1467

acerylgalactosamine,

in colonic proliferation,

106:1714-ss

testinal polypeptide and (opossum),

Gallbladder

against (baboon),

primary sclerosing cholangitis

106:13

Gastroesophageal

Gastrointestinal

contractility,

hepatitis C virus and, 106:248-cr phosphatidylcholine

Folinic

enterotoxin

esophageal secretion and,

cholecystokinin

pathogenesis for, 106:822-c Fibrosis cytokines and, 106:534-vodd

Flatus,

staphylococcal

1,3-N-a! Galactose-P

matrix and (rat), 106:473

106:1477

reflux disease

(cat), 106:624

B and (mouse), 106:450 Galactose,

cholestatic

during acute

stress, 106:1403-tmig,

surgery prevents,

106:973

extracellular

junction,

Gastroesophageal

percutaneous endoscopic gastroscopy and,

epithe-

106:775-cr

Fibrosing

106: 1-tmig,

lower esophageal sphincter function and

Na+ transport and, 106:125

Fibronectin

partern of,

eosinophilic,

Gastroesophageal

106:464

Sandhoff disease and,

satiety

106:1168,

106:3

106:2-tmig,

(FGFs),

ha1 cell function and, 106:1254 Fibroblasts,

response,

Gastroenteritis,

athy and (rat), 106:567 Fibroblast

(GRP),

106:814-ss

lactate-anion exchanger and (rat), 106: 5 59

thy and, 106:500-cr Fibrinogen,

Gastrocolonic

mander and (mouse), 106:285-tmig,

colon cancer and, 106:883

peptide

and, 106:1137tmig, 106:1374-e

duodenal distension and,

infections,

wooden chest and, 106820-c

dietary,

Fibrin,

ischemia and (cat),

and, 106:512-srr Furano

and, 106:1162 Fiber,

Gastrin-releasing

106:583

calcium carbonate supplementation

Fentanyl,

short-chain fatty acids and (rat), 106:375

106:464

intestinal

Fundic relaxation,

106:277-c,

106:279-c Feces,

colon cancer and, 106: 1263

106:629

106:1301

history of, 106:1126-br

secretion,

Gastrin overview of, 106:550-br

herbal tea heparitis in (mouse),

cultured, toxic oil syndrome and, 106:691

Fecal occult

Gastric

eicosanoid production and (dog), 106:297

recep-

106:1485

dogs, phase III activity in,

tmig, 106:160 procollagen (Y,), 106:691 ulcerative colitis and, 106:557-tmig, 106:637

1752

SUBJECT

vasoactive

GASTROENTEROLOGY

INDEX

intestinal

polypeptide,

GP53,

in platelet

106:1467 Gene

106:1638,

insufficiency,

in liver disease, as herbal

(mouse), Glibenclamide,

106:285-tmig

K+

in colitis

conju-

overgrowth

and,

transport

peptic

106:389

of (rat),

precore

lO6:1418

absorption

carbohydrate index,

and,

HCOj+,

quality

of life

lO6:664,

106:828-

in HBV virus and,

and,

B virus and,

106: 1000

lO6:664,

106:828-

106: 1006 C virus and,

Headaches,

in liver cancer, prodrugs

(rat),

Heart

106:1048

alkaline

response

Whipple’s

and (rat),

HCV and, Heat

liver disease and, atrial natriuretic

peptide

liver failure

due to

and (rat),

Height,

and (mouse),

106:464 gastric

and (cat), 106:629

injury

and (rat), lO6:ll99

gastrin

and,

glycoprorein

natural

gastric

at-acid

and, 106:231

Glycine

lO6:1137-tmig,

in hepatocytes

Hematoma,

(rat),

106:168 glutathione

and (rat), 106:1199

infection

Glycoproteins

with (monkey),

mucin,

106:85

Hemophilia

106:1054

Glycoursodeoxycholate,

Golgi vesicles, (rat),

and,

endothelin

incomplete

septal cirrhosis

Hepatitis

hepa-

106:480

liver,

106:1455

system A activity

and

endothelin

(HCV)

of, 106:1344-cr

agammaglobulinemia alcoholic

and,

106:1072-cr

liver disease and,

l06:1085-srr

hepatitis

type 2 and,

as community-acquired cryoglobulinemia

infection,

and,

septal cirrhosis

interferon

RNA,

B virus, and,

106:459

(Y for, 106:558-tmig,

106:686

in, 106:248-cr

autoantibodies and,

and,

106:1672-cr

106:1118-e

in liver transplants,

106:994

carcinoma

asymptomatic

hepatitis

B virus carriers

106: 1000

micrometastatic,

assay for, 106:264-e

factors

for recurrence

of,

106:1618 prognostic

factors

and,

106:720

proton 106:500-cr

lO6:1291

of hepatitis

106:1048

and,

irradiation

after hepatic

resection

for, 106:1032

growth

liferation

106:1668-cr

Hemorrhagic

106:828-

106:1006

C virus

Hepatocyte

radiation-induced

106:459

in, lO6:243-cr

of acute vs. chronic,

tmig,

assay, tumor necrosis fac-

Hemorrhage

106:1723-c hepatic

1 and (rat),

B, gene therapy

and,

of, 106:664

mutation

serology

predictive

gastrointestinal,

C virus,

106:1080-srr

in vitro replication

and,

106:1079-srr cholesterol-rich

membranes and, 106:1333 Gold standard, diagnostic, for chronic titis,

liver, preeclampsia

tor LYand,

in colon cancer cells and,

and,

Hepatocellular

plaque

106: 129 1

to, 106: 1388-ss

pathogenicity

106:988 Hemolytic

and,

immunity

LKM-1

106: 1398-c

106:1263

Hemoglobin,

acid, in acute pancreatitis

(rat), lO6:207 fectins

gene rherapy

106: 1668-cr

Glycodeoxycholic

HIV and,

of by hepatitis

liver failure

106:1405

cytoprotection,

cryoglobulinemia displacement

incomplete

trials and,

cancer and,

(HBV)

antibodies,

106:823-c

106: 112 1 -ss

106:1174

free radicals

B virus

core antigen

in displacement

colon cancer risk and,

dyspepsia

Hepatitis

106:248-cr

Helicobacter pylori

herbal tea hepatitis

for,

106:1596

106:65

106:143

gold standard

106:1603

Saccharomyces boulardii and,

treatment,

106:1085-srr

cholan-

106:161

liver failure due to HCV and,

cholestatic,

autoimmune

disease and,

transplantation,

106:405 Glutathione

diagnostic

adaptation

106:782-cr

in glucocorticoid

sclerosing

106:1-tmig,

106:1723-c

precore

106:367

synthetase,

primary

106:1048

carriers

gastric

106:1312

oxidant

malabsorp-

lO6:1006

mutation

hepatitis

pharmacology

depletion,

106:907

106:287

tmig,

106:1366-vodd

biliary,

106:324

of, 106:60

B virus and,

hepatitis

and,

106:1698-e

alcoholic

and (rat),

l06:243-cr

and (rat),

and (piglet),

sodium

Glutarate,

ion trans-

HBsAG

cryptosporidiosis

Glutamine

chronic,

disease and,

asymptomatic

nutritional

106:125

infusions

tmig, 106:423

Glutamine intestinal

asymptomatic,

106:1042

106:248-cr

Harvey-Bradshaw

hepatitis

glutathione

intracel-

106:763

thrombosis,

gitis and,

HBeAg

106:615

106:1199

Glycans,

and,

H2 nonproducers,

106:1562 oxidase,

vein

and,

106:828-tmig,

lO6:1190

radiation-induced

stricture

and (rabbit),

metabolism

Hepatic

Hz antagonists

and,

Glucose

and (rat),

HI antagonist,

Glucose

colonocyte

ana-

tion and, 106:1726-c and,

106: 1150

cholecystokinin-coupled lular signaling

port dysfunction induced

(rat),

mucin

Heparin,

autoimmune,

continuous therapy

labeled,

bacterial

cirrhosis

and (rat), 106:1505

acute colitis

106:405 Glucosamine,

bicarbonate

biliary

food protein-induced

phylaxis

106: 1068-cr

by (rat), 106:480 gates,

cells,

106: 1342-cr

Na+ transport

prodrug

and (pig),

Hepatitis

of, in Alagi-

system A activity

HEp-2

E. coli and,

H+

ATP-sensitive

Glucocorticoid-dextran

autoanti-

lO6:464

hyperintensity

hepatic

cirrhosis,

106:193

primary

Guanethidine, due to

C virus in, 106:1603

he’s syndrome, Glucagon,

and,

and (rat), 106:1016

pallidus,

disease,

106:1076-srr

tea, hepatitis

vascular

channels Globus

Graves’

106:285-tmig,

hepatitis

biliary

bodies against,

106:1711-e

for GI and liver disease,

Germany,

heat shock gene expression

No. 6

106:177

gp2 10, in primary pancreatic

Germander,

106:827-tmig,

106:840

therapy

for exocrine

Gentian,

activation,

Vol. 106,

factor,

hepatocyte

pro-

and (rat), 106: 1024

Hepatocytes mucosal,

106:544-ss

shock 1 and (rat), 106:988

albumin

mRNA

CD1 molecule glycine

and,

106:239

and (rat),

cytoprotection

106:ll43

in (rat),

106:168

SUBJECT INDEX

June 1994

heat shock gene expression and (pig),

cr,P,-positive,

tumorigenicity

of (nude

cavitation and, 106:937

liver failure due to HCV and, 106:248-cr

lectins and, 106:85

perivenous, long-term ethanol feeding and

recombinant growth factors and, 106: 1254 HT29-D4

transcription Hepatoma,

factors and (rat), 106:1625

gene therapy and, 106:1080-srr

Hepatomegaly,

hepatic vein thrombosis

and, 106:828-tmig, HEPES

buffer,

106:1042

nitric oxide synthase and

tea hepatitis,

due to germander

(mouse), 106:285-tmig, Hereditary

concentration

hepatic iron

colorectal

can-

cer, genetic linkage and, 106:815-ss Herpes

simplex

virus (HSV),

esophageal

Herpes-type

viruses,

oral hairy leukoplakia

and, 106:506-cr Hexamethonium,

colonic relaxation and

(dog), 106:606 Hexosaminidase

B deficiency,

diarrhea

and autonomic dysfunction in, 106:775-cr High-performance

liquid

chromatogra-

phy (HPLC) cyclosporine enemas and, 106: 1429 eicosanoid production and (dog), 106:297 Histamine food protein-induced

anaphylaxis and (rat),

106:1505 phase III activity and (dog), 106:1533 radiation-induced

ion transport dysfunc-

tion and (rat), 106:324 Histoautoradiography,

rectal epithelial

proliferation

and, 106:982

Histop&zsma spp., esophageal infections and, 106:515-srr HLA Al-B8-DR3,

autoimmune

hepatitis

and, 106:1321 HLA antigens,

autoimmune

diseases and,

106:1676-srr HLA B27,

in ulcerative colitis,

106:557-

tmig, 106:637 HLA DR4,

primary sclerosing cholangitis 106:160

106:3

peroxidase,

protein,

in postischemic

liver (pig),

HT29

cl.19A

HT29

tmig, Hunger,

cells, tumor necrosis factor LY

colon cancer

IB4 monoclonal and, 106:1451

serum, sinusoidal perfusion

Hyaluronate

Ice immersion,

normal colonic epi-

Idiopathic

thelium and, 106:1242 acid

Idiopathic

and (rat), 106: 1106-rc

breath

Hydrogen

peroxidase,

106:615

glutathione metabolites,

and eicosa-

acid, lactate-anion

exchanger and (rat), 106:559 in carcinoid diarrhea,

recombinant growth factors and, 106:1254 IgA dexamethasone and (rat), 106:35 vasoactive intestinal polypeptide and, 106:576 IgE, Amyfostoma caninum and, 106:3

hormone and,

Helicobacterpylwi and, 106:1405 primary sclerosing cholangitis and, 106:185

radiation-induced

ion transport dysfunc-

IgM, hepatitis B virus and, 106:828-tmig, 106:1006

tion and (rat), 106:324 Hypercoagulability,

in inflammatory bowel

IL-lra

gastric mucosal, substance P

and (rat), 106:286-tmig, Hypergastrinemia,

gene, in ulcerative colitis, tmig,

disease, 106:281-c Hyperemia,

ci-

gastrin and, 106: 1263

106:1184 corticotropin-releasing

disorder,

I&-J cholesterol gallstones and, 106:749

5-Hydroxytryptamine antagonist,

motility

IEC-6 cells

noid production and (dog), 106:297 cy-4-Hydroxy-cinnamic

intestinal

Saccharomycesboulardii and, 106:65

(rat), 106:1199 Hydroxyarachidonate

HLA anti-

sapride and, 106:916

test, bacterial overgrowth

and, 106:557-tmig,

106:1477

hemochromatosis,

gens and, 106:1683-srr

gastric mucosal lesions and (rat), 106: 1524 Hydrogen

free radicals and

acute stress reactions and,

106:1403-tmig,

receptor,

bFGF-CS23

antibody,

(cat), 106:629

and, 106:280-c

Ileocolonic

colon cancer and,

106:557-

106:637 anastomosis,

short-chain fatty

acids and (rat), 106:375

106:440

Ileorectal

anastomosis,

familial adenoma-

tous polypsosis and, 106:285-tmig,

106:1263 5-Hyperoxytryptamine,

106:362

food protein-inIleum

duced anaphylaxis and (tat),

bicarbonate transport and (rabbit),

106:1505 Hyperplasia-dysplasia

cancer

response,

106:1562

hypothesis,

distension,

peanut lectin and, lO6:117

motor patterns of in vitro (rat), 106:649

primary biliary cirrhosis

radiation-induced

pancreatitis

gastropathy,

Ileus, postoperative,

bacterial overgrowth and, 106:615 during cardio-

pulmonary bypass, 106:318

cisapride and, 106:827-

tmig, 106:924

endoscopic ul-

trasonography and, 106:820-c

intestinal,

106:324

and,

106:810-e

106:557-tmig,

ion transport dysfunc-

tion and (rat), 106:286-tmig,

and, 106:1342-cr 106:742,

in colonic relaxation (dog),

106:606

Anrylostoma can-

inum and, 106:3

Hypoperfusion, cells

peptide

and, 106:143

106:709

cholecystokinin

Hypochlorhydria,

and, 106:1514

damage,

rapid total paracentesis and, 106:558-

Hypertrophic

106:177

intestinal injury and (rat), 106:346

hepatocyte, atria1 natriuretic

immunity

Hypertriglyceridemia, tumor necrosis

factor (Y and, 106:1514 HSP-72

Hypoxia/reoxygenation-induced

Hyperthyroidism,

canine, in human enteritis,

106:1-tmig, Horseradish

Hypoxia,

Hypersensitivity

and, 106:1-tmig, Hookworms,

esophageal infections and, 106:520-srr

106:859

nitric oxide and (rat), 106:367

hor-

mone and, 106:859

and, 106:823-c

Hydrochloric

infections and, 106:5 16-srr

(HPA)

axis, corticotropin-releasing

virus (HIV)

oral hairy leukoplakia and, 106:506-cr Humoral

in liver cir-

Hypothalamic-pituitary-adrenal

immunodeficiency

Hyaluronan,

in, 106:674

nonpolyposis

osmoreceptors,

rhosis, 106:678

cells, Saccbaromycesboulardii and,

anti-HBc

lO6:464

hemochromatosis,

Hereditary

Hypothalamic

hepatitis C virus and, 106:1072-cr

(opossum), 106: 1444 Herbal

Human

injury and

Sandhoff disease and, 106:775-cr

106:65

polyamine metabolism and (rat), 106:1024

intestinal

(rat), 106:346

hepatitis B virus and, 106:664

(rat), 106:473

Hypotension hypoxia-induced

mice), lob:19

106:177

1753

Immune

response

cytokines and, 106:533-vodd esophageal infections and, 106:509-srr fibrosing cholestatic 106:822-c

hepatitis and,

1754

SUBJECT

Immunoaffinity

chromatography,

glycoprotein Immunoblot

GASTRDENTEROLOGY

INDEX

c~i-acid

tumor necrosis factor (Y and, 106:1404-

analysis,

raw kidney beans in

Inflammatory

small intestine and (rat), 106:73 Immunocytochemical

analysis

raw kidney beans in small intestine and

CD1 molecule and

106:286-tmig,

106:287

antibody,

Immunohistochemical

assay, priand,

106:185

primary scle-

and, 106:1-tmig

106:433

intracellular

signaling and,

corticotropin-releasing

hormone and,

106:177

106:248-cr,

106:558-tmig,

106:686

lower esopha-

106:381

area, lymphatic microvessels

lower esophageal sphincter

function and (cat), 106:624 Italy, hepatitis C virus in, 106: 1603

in (rat), 106:1548

cryptosporidiosis

and (piglet),

106:1418

Interleukin

1 (IL-l)

colonic secretion and (rat), 106:1493

interleukin

E. coli enteritis and (rabbit),

1 and (rat), 106:1493

metronidazole and, 106: 127 1

enterocolitis

P, purinergic

receptor antagonist,

receptors and (rabbit),

106:1485 alcoholic liver disease

and, 106:1085-srr formula,

autoimmune

in enterocolitis

and (piglet),

Interleukin

ICU(IL-l@,

106:1215

Interleukin

(rat),

ulcerative colitis

l/3 (IL-l/?),

Interleukin

cow’s milk allergy in, 106:1514

2 (IL-2),

inflammatory bowel

disease and, 106:557-tmig,

digestive disorders in, 106:1126-br Inflammation

Interleukin

E. cofi enteritis and (rabbit),

Interleukin 106:306

eicosanoid production and (dog), 106:297 parasitic, mast cells in, 106:286-tmig primary sclerosing cholangitis

and,

106:185

Interleukins,

106:637

tumor necrosis factor u and,

106:1514 Intermediate

filaments,

JejeunaI-ileal

in GI malignan-

106:1342-cr

transposition,

enteroendo-

crine cell adaptation and (rat), 106:1576 Jejeunoileum necrotizing enterocolitis

and (piglet),

106:1215 resection, Menhaden oil and (rat), 106:94 Jejeunum Cryptospwiu’iumin (calf, human), 106:28 indomethacin-induced

injury of (rat),

106:567 lactate-anion

exchanger in (rat), 106:559

short-chain fatty acids and (rat), 106:375

in, 106: 117

failure,

106:637

Intestinal

and,

lymphocyte adhesion in, 106:596

vessels, somatostatin receptors in,

Intrahepatic

106:95 1

Inrraluminal gitis,

sticky platelets in, 106:827-tmig, 951

106:840

collaterals,

hepatic vein

distension,

in erosive esopha-

106:lOS

In vivo gene transfer,

channels,

in cirrhosis (rat), 106:1016

in GI malignancies,

Keratinocyte

growth

factor,

106:1326 epithelial cell

function and, 106:1254

thrombosis and, 106:1042

somatostatin receptors and, 106:828-tmig,

K*TP Keratin,

106:951

peanut lectin and, lob:117

K+, Naf transport in proximal colon and, 106:125

clinical nutrition

106: 1369-vodd

in, 106:281-c

substance P and, 106:828,

bypass, calcium supplementation

and, 106:1162 Intestinal

genes in, 106:557-tmig, hypercoagulability

disease and, 106:557-tmig,

Intestinal

in, 106:828-tmig,

106:945 colonic proliferation

106:637

10 (IL-IO), inflammatory bowel

reversible, in PBC due to hyper-

thyroidism,

cies, 106:1326

bowel disease (IBD)

autonomic functioning

106:637

2p (IL-2/3), ulcerative colitis

and, 106:557-tmig,

cytokines and, 106:533-vodd

Jaundice,

106:637 gastric emptying

and (rat), 106:1568

Infants

hepatitis in, 106:1676-srr

hepatitis C virus in, 106:1596

and (rat), 106:960

and, 106:557-tmig,

necrotizing enterocolitis

106:160,

Jaw

106:306

106:960

solvents,

Inflammatory

tension responses,

Isoproterenol,

tumor necrosis factor (Y and, 106:1514 Interfollicular

atria1 natri-

geal sphincter pressure and (cat),

gastric emptying and (rat), 106: 1568

Infant

Isometric

7 (IFN-y

106:450

Indomethacin

injury,

uretic peptide prevents (rat), 106: 143

staphylococcal enterotoxin B and (mouse),

oral hairy leukoplakia and, 106:506-cr chain isoforms and, 106:829

106:840 Ischemia/reperfusion

CY(IFN-cu), for hepatitis C virus,

Interferon

laminin A-

platelet activation and, 106:827-tmig,

106:200

Immunosuppression

immunofluorescence,

and (piglet),

106:1215

Interferon

hepatitis C virus RNA and, 106:994

necrotizing enterocolitis

Insulin

CD1 mole-

esophagus and, 106: 17 17-ss

1 and (rat), 106:988

free radicals and (cat), 106:629 heat shock gene expression and (pig),

exocrine pancreatic secretion and (rat),

cule and (rat), 106:1143

of, 106:674

Ischemia

lactase gene and (rat), 106:1223

enterocyte response to (rat), 106:49

staining,

106:324

Iron

endothelin

lactase gene and (rat), 106:1223 Immunoperoxidase

radiation-in-

and, 106:500-cr

In situ hybridization

MUCI

mucin expression and, 106:353

dysfunction,

duced (rat), 106:286-tmig,

diffuse hemorrhagic gastroenteropathy

spasmolytic peptide and (rat), 106:336

inflammatory bowel disease and, 106:596

in ion transport dysfunc-

hepatic concentration

106:859

and (rat, human),

amino

test and, 106:488

alcoholic liver disease and, 106: 1095-srr (IP,)

106:763

analyses

aflatoxin Bl-adducts

Industrial

radiation,

No. 6

tion (rat), 106:286-tmig

E. cofi and, 106:1150

rosing cholangitis

Indirect

Ionizing

Ion transport

immunoperoxidase

Inositol-1,4,5_triphosphate

of chronic liver diseases,

106:1676-srr Immunoglobulin

quality of life and,

CCK-coupled

(rat), 106:1143 Immunogenetics,

bowel disease question-

mary sclerosing cholangitis

spasmolytic peptide and (rat), 106:336

chromatography,

acid consumption

naire (IBDQ), Inhibition

(rat), 106:73 Immunofluorescence,

Ion-exchange

tmig, 106:1455

and, 106:231

Vol. 106,

Ketotifen,

gastric mucosal blood How and

(rat), 106:440 Kidney beans, raw, small intestine exposure to (rat), 106:73

in GI and liver dis-

eases, 106:1077-srr

Kidneys,

misoprostol effects in cirrhosis and, 106:557-tmig,

106:658

June 1994

SUBJECT

Lactase

Limiting

gene, expression regulatory Lactase

106:1223

of (rat),

mechanisms

phlorizin

and,

hydrolase,

106: 1376-e

Linoleic

activity

Linoleylanilide,

of,

acid,

106:1233 Lactate-anion

in jejunal

membrane

(rat),

dehydrogenase, sion injury

Lactose,

baso-

capacity

Lipase,

106:143 and,

overgrowth

hypothermic

and,

acid consumption

cardiopulmonary

106:883 and,

test and,

in primary

sis, autoantibodies Lamina

biliary

against,

liver disease and, 106: 1095-srr and,

106:691

cytokines

mucosal

and,

and,

106:534-vodd

lymphocytes,

bowel dis-

carbonate and,

polypeptide

and,

106:576

hepatocyte

attachment

colonic

Laparoscopic

epithelium

and,

cholecystectomy,

recurrence

and,

106:1242 gallstone

106:1-tmig

Laparotomy Ancyfostoma caninum and, cisapride

and,

Large

intestine,

Laser

Doppler

blood

and,

deficiency,

106:883

gene therapy

and,

alcoholic

106:85,

metranidazole

and,

106:117 106: 127 1

oral hairy, in ulcerative

colitis,

B4

indomethacin-induced (rat),

enteropathy

and

and,

transport

dysfunction

ion

and (rat),

factors

laxis and (rat), Li+, Na+ transport

anaphy-

in proximal

colon and,

microscopy, and (rat),

ileal motility 106:649

patterns

and,

and (rat),

B virus carriers

in, 106:678

for recurrence

cholangitis

A activity

and,

and (rat), 106:480

syndrome

cholangitis

hepatitis

C virus and,

HLA antigens

LKM-1

and,

106:1684-srr and, 106: 113%

106:1284

autoantibodies, and,

hepatitis

106:1603,

C virus

106:1672-cr

hypoxia-induced and (rat),

resec-

intestinal

injury

106:346

fats, in mucosal

adaptation

(rat),

106:94 Loss of heterozygosity

106:1143

106:994,

biliary cirrhosis

tmig,

(LOH),

tric carcinoma,

for, 106:1032

and (rat),

106:1068-cr

in, 106:239

106:1672-cr

and,

after hepatic

and,

mRNA

of,

106:720 irradiation

gene expression

106:177

sclerosing

Long-chain factors

106:1068-cr

heat-shock

albumin

Lower esophageal

AK,

in gas-

106: 1584

sphincter

(LES) pres-

sure

cirrhosis body composition

in nonalcoholic,

assymmetry in (cat), 106:381 bolus gastrostomy

captopril

for, 106:1131-c

hepatitis

C virus and,

tmig,

106:248-cr,

malnutrition

Luminal

in, 106:1404-tmig renal effects in, 106:557against

(baboon),

in HBV virus and,

and,

106:108

acid,

Ez and,

106: 1397-c

esophageal

secretion

and,

and,

106:973 Lung cancer,

~53 gene mutation and,

LY267108,

106:42

lower esophageal sphincter f&c-

Lymphatic

microvessels,

in vivo visualiza-

tion of (rat), 106:1548

106:243-cr toxic oil syndrome

106:2-

tion and (cat), 106:624

106:257-e

mutation

and,

and (cat), 106:624

106:2-tmig,

106:658

106:152,

erosive esophagitis prostaglandin

106:459

106:459

feeding

106:13

LY267108

106:686

septal,

macronodular,

tmig,

B and

106:160

106:264-e

106:160

precore

106:125

primary

in, 106: 13 12

phosphatidylcholine

106:1505

manganese

LNMA,

sclerosing

misoprotil

106:324 food protein-induced

feeding

ethanol

primary

osmoreceptors

incomplete

106: 127 1

Dq, radiation-induced

Leukotrienes,

in, 106:239

106:558-tmig,

106:567

metranidazole Leukotriene

in, 106:674

long-term

Alagille’s

106:1611

106:506-cr Leukotriene

106:1721-br

hepatitis

CD1 molecule

enterotoxin

106:450

transplantation

synthetase

primary

106:828-

iron concentration

106:262-e

106:lOOO

predictive

proton

in colon cancer,

Leukoplakia,

and,

mRNA

tion,

liver disease and,

106:1085-srr Leukocytes,

and, 106: l-

106:225,

106:1085-srr

prognostic

106:1079-srr

staphylococcal

postischemic,

106:1618

diacylglycerols

LDL receptor Lecithin,

diseases

hepatic bypass and,

106:318 acid,

biliary

and,

106:1042

(mouse),

system and,

glutamine

flow and (rat),

cardiopulmonary

food protein-in-

Liver

and,

106:440 hypothermic

and,

and (rat),

recurrence

106:215,

asymptomatic flow velocimetry

mucosal

106:1301

assay for micrometastatic,

disease and,

vein thrombosis

in (pig),

alcohol

106:168

and,

106:473

gallstone

tmig,

factor

and (rat),

preeclampsia

tmig, injury,

inhibitors,

albumin

106:924 Sandhoff

and,

cancer

106: 1-tmig

106:775-cr gastric

carcinoma

anaphylaxis

Lithotripsy,

106:473 normal

cells, platelet-activating cytoprotection

hepatic

106:1505

to ECM and (rat),

of, 106:1676-srr C virus in, 106:248-cr

106:1668-cr 106:810-e

in vivo gene transfer

duced

of, lO6:829

106:285-tmig,

106:1301

hemorrhage,

(LPS), platelet-activat-

5-Lipoxygenase isoforms

in (mouse),

hepatitis

and,

106:1077-srr

Laminin A-chain

supplementation

hepatocellular

Liposomes,

intestinal

106:1291

for, 106:1076-srr

immunogenetics

and (rat),

106:742,

ing factor and,

cells, vasoactive

and,

gene therapy

106:1162

Lipopolysaccharide

ease, 106:596 mononuclear

adaptation

106:1032

in inflammatory

in, 106:134

cryoglobulinemia

glycine

pancreatitis Lipiodol,

propria

bile acid kinetics

failure,

106:94

cirrho-

106:193

in

disease

fat-storing

bypass and,

K channels

106:464

fecal, calcium

B receptor,

ATP-sensitive

1755

106:1016

germander

toxic oil syndrome dietary,

106:615

106:318

Light

and,

toxic oil syndrome

peroxidation

alcoholic

106:1233

vascular (rat),

Lipids

bacterial

Lectins,

intes-

106:576

106:488 Lipid

Lactulose

Laurie

vasoactive

and,

diacylglycerols

amino

106:559

ischemia/reperfu-

and (rat),

digestion

Lamin

analysis,

106:691 exchanger,

lateral Lactate

dilution

tinal polypeptide

INDEX

106:691

Lymphocytes

1756

SUBJECT

GASTROENTEROLOGY

INDEX

alcoholism and, 106:1724-c

Mesalamine,

inflammatory bowel disease and, 106:596

Mesalazine,

Peyer’s patches and (rat), 106: 1548

Messenger

Lymphoma,

gastrointestinal,

for colitis,

106:846

106:239

Monosaccharides,

glutamine Macronodular

cirrhosis,

incomplete septal

IL-lra,

cirrhosis and, 106:459 Macrophages,

indomethacin-induced

enter-

resonance

imaging

in gallbladder filling and emptying (dog),

1, 106:960

106:1652

spasmolytic peptide, 106:336

complex

(MHC)

Malabsorption,

bacterial overgrowth and,

106:557-tmig,

Metabolic

disorders,

gene therapy and,

Methylene

pancreas and, 106:1054

acid, hepatic

blue, toxic oil syndrome and,

tumor necrosis factor (Y and, lO6:15 14

hypothermic cardio-

bis(guanylbydrazone),

patocyte proliferation

cisapride and, 106:916 lower esophageal sphincter pressure and

Mucus

he-

Multiploidy,

in glucocorticoid

postpran-

dial colonic hypertonic response and,

pro-

platelet-activating

fac-

gastric mucosal blood flow and (rat), 106:286-tmig,

1 and (rat), 106:1493

radiation-induced

ion transport dysfunc-

tion and (rat), 106:286,

324

platelet activation and,

106:827-tmig,

acute stress reactions and,

106:1403-tmig,

106:1477

allelic deletions of, in stomach

colitis,

“transatlantic”

Mechanoreceptors,

duodenal, 106:583

oil, dietary, in mucosal adapta-

tion (rat), 106:94 migrating motor complex and,

106:827-tmig,

106:924

resin infusion, and (rat), 106:702

portal hypertension

Mycobacterium

enlargement and reorganization

of (rat), 106:73 inclusion

transplantation Migrating

motor

disease,

intestinal

for, 106:771-cr

complex

food protein-induced

anaphylaxis and (rat),

kidney in cirrhosis and,

106:557-tmig,

esophageal in-

cholecystokinin-cousignaling and,

Myeloperoxidase glucocorticoid

pmdrugs and (rat), 106:405

hypoxia-induced

intestinal

injury and

(rat), 106:346 radiation-induced

ion transport dysfunc-

tion and (rat), 106:324 Myenteric

plexus,

vasoactive intestinal

polypeptide and (opossum), 106:1467 Myristic

acid, diacylglycerols

and, 106:883

Na+ acute colitis and (rat), 106:1190

106:924

Mistletoe,

com-

106:763

(MMC)

106:1505 postoperative ileus and, 106:827-tmig, Misoprostol,

intracellulare

tuberculosis,

Myelin basic protein,

unify-

cisapride and, 106:916

cancer, 106: 1584

auium

pled intracellular

epoxide hydrolase and (mouse), 106:464

Microvillus

colonic relaxation and

plex (MAC), esophageal infections

106:840

Microsomes

Microvilli,

blockade,

fections and, 106:522-srr

alcoholic liver disease and, 106:1085-srr

106:440

technique and,

and, 106:523-srr

flora, altered, esophageal infec-

ing concept and, 106:1727-c

Mast cells

crypt-isolation

Mycobacterium

tions and, 106:510-srr

Microscopic

tor and, 106:1301

in pan-

106: 1645

(dog), 106:606

leukocyte adhesion and,

Microinfarction,

106:1184 Mass spectrometry,

Microbial

and, 106:735

106:100

106:1271 assembly,

adherent bacte-

model of carcinogenesis,

Muscarinic

Methylprednisolone, Metronidazole,

106:924

intestinal,

neck cells, gastric, pancreatic secre-

Multihit

and (rat),

drugs (rat), 106:405

(cat), 106:381 postoperative ileus and, 106:827-tmig,

barrier,

ria and, 106:255-e

creatic carcinoma,

106:1024

erosive esophagitis and, 106:108

Math testing,

Mucosal

pulmonary bypass and, 106:318 Methylglyoxal

Manometry

Menhaden oil and

tory trypsin inhibitor

3-O-Methyl-D-glucose,

dexamethasone and (rat), 106:35

adaptation, (rat), 106:94

disease and, 106:782-cr

106:691

bacterial overgrowth and, 106:615

106:353,

106:389

system A activity and (rat), 106:480

Mannitol

interleukin

colon cancer and, 106:285-tmig,

Mucosal

2-(Methylamino)-isobutyric

in chronic liver disease,

in vitro ileal (rat),

esophageal secretion and, 106:973

Whipple’s

106: 1068-cr

Manometry-barostat

patterns,

labeled, hepatitis B virus and, 106:664

106:286-tmig

functional tests of, 106:1365-vodd Manganese,

Motility Mucin

Methionine

for primary sclerosing cholangitis, 106:1404-tmig

prokinesia and,

106:649

Methotrexate

106:615

Malnutrition in cirrhosis,

disorders, 106:1112-e

alcoholic liver disease and, 106: 1085-srr

106:450

Mercox

Motility

106: 1080-srr

staphylococcal enterotoxin B and (mouse),

Meperidine,

phase III activity and (dog), 106:1533

106:1467

autoimmune diseases and, 106:1676-srr

Menhaden

106:691

vasoactive intestinal’polypeptide,

disease and, 106:782-cr

Major histocompatibiltiy

MCCIAPC,

lower esophageal sphincter function and (cat), 106:624

procollagen a,),

tmig, 106: 1042

in gallbladder filling and empty-

Motilin

106:960

hepatic venous obstruction Whipple’s

hepatitis B virus

ing (dog), 106:1652

Alagille’s syndrome and, 106:1068-cr and, 106:828-

asymptomatic

Morphine,

lactase phlorizin hydrolase, 106:1233

(MRI)

cardiopul-

carriers and, 106:lOOO

lactase, 106:1223

opathy and (rat), 106:567 Magnetic

Montreal,

hormone, 106:859

106:177

interleukin

hypothermic

monary bypass and, 106:318

synthetase, 106: 13 12

HSP-72,

106:193

shock wave cavitation and, 106:937

106:1143

106:828-tmig,

No. 6

antibodies against, in pri-

mary biliary cirrhosis, Mitosis,

corticotropin-releasing

genetic linkage and,

106:815-ss

Mitochondria,

RNA (mRNA)

CD1 molecule,

Lynch syndrome,

lO6:1429

for Crohn’s disease, 106:553-c

albumin,

in adults,

106:399,

Vol. 106,

106:658

in liver disease, 106:285-tmig

eicosanoid production and (dog), 106:297 enteric cryptosporidiosis

and, 106:28

L-glutamine and, 106: 1698-e

June 1994

SUBJECT INDEX

misoptostol

and, 106:658

transport, Na+-H+

exchange, (piglet),

Na+,K+

acid, deglutitive 106:827-tmig,

in cryptosporidiosis

Nitric

insulin and (tat), 106:200

nitric oxide synthase and (opos-

for erosive esophagitis,

intestinal

Non-A,

non-B,

misoptostol

in-

(NANC)

(rat), 106:207,

enterocolitis,

microvillus inclusion disease and,

regulation,

(tat), 106:286-tmig,

dysmotility,

106:827-tmig,

Northern

blotting

glutamine

intestine and, 106:827-tmig,

Northern

106:859,

manganese,

Nuclear

106:1068-ct

hepatitis B

analysis

synthetase and, 106: 13 12

Europe,

autoimmune

hepatitis

envelope

Nucleoproteins,

acute colitis and (rabbit),

proteins,

Nutrition,

alcoholic liver disease and,

modern, in health and disease,

106:1721-bt

and, 106:500-ct free radicals and (cat), 106:629 indomethacin-induced

entetopathy

and

O,+, heat shock gene expression and (pig), 106:177

(rat), 106:567

Oat bran, dietary, diacylglycerols

inflammatory diarrhea and (rabbit), 106:1403-tmig,

106:1554 Obesity,

platelet activation and, 106:827-tmig,

Okamoto’s

106:840 NH4+, Na+ transport in proximal colon and, 106:125 adenine

dinucleotide,

alco-

holic liver disease and, 106:1085-srt Nicotinic

blockade,

colonic relaxation and

fundoplication, 106:1391-ss

fate of,

hepatitis C virus

and, 106:1603 Oleic acid, diacylglycerols Oleylanilide,

and,

and, 106:1451

classification,

and, 106:883

toxic oil syndrome and,

106:69 1 Oligonucleotide probes, cholangitis

(dog), 106:606 Nissen

106:883 cholecystokinin

short bowel syndrome

and, 106: 1369-vodd Ornithine

decarboxylase

enterocytes and (tat), 106:49 hepatocyte proliferation

and (tat),

106:1024 Otopharyngeal

flora, esophageal infections

and, 106:522-srr Oropharyngeal

osmoreceptors,

in liver cit-

rhosis, 106:678 hepatic, in cirrhosis,

106:678 Ouabain,

insulin and (tat), 106:200 medications,

alcoholic

liver disease and, 106:1085-srr Oxalate precipitation, Oxidant

injury,

E. coli and, 106: 1150

glutathione

and (tat),

106:1199 Oxidation,

colonocytes and (tat), 106:423

Oxygen radicals,

alcoholic liver disease and,

106:1085-str Oxygen

saturation,

endothelin

1 and (tat),

autoantibodies

106:1096-srt

106:1208

diffuse hemorrhagic gastroenteropathy

patterns and

106:988

against, 106:193

sulfasalazine and, 106:1429

Neutrophils

Nicotinamide

Oral rehydration,

and, 106:1321

106:Y5 1

ileal motility

(tat), 106:649

spasmolytic peptide and (tat), 106:336

achalasia and, 106:1397-c

Neutropenia,

asymptomatic

virus carriers and, 106:lOOO

cisapride and,

106:916

Sandhoff disease and,

106:775-cr America,

Oral pressures,

Over-the-counter

gastropathy and, 106:1726-c

North

106:875

in carcinoid diarrhea,

106:1184

Osmoreceptors,

and (rat), 106:567

familial adenomatous polypsosis and,

inhibi-

Neuropeptides

Neurotoxicity,

drugs

(NSAIDs)

Norepinephrine,

and (dog), 106:606 tion and, 106:827-tmig,

106: 1596

106:362

colonic relaxation

deglutitive

in hepatitis C virus

anti-inflammatory

entetopathy

106:324

2 antagonist, intramural,

transmission,

poly-

mast cells and

in HBV virus,

knives,

Nonsteroidal

vasoactive intestinal

alcoholic liver

106:243-ct

tonic, ileal motility pat-

peptide and (opossum), 106:1467 Neuroimmune

mutations,

Nonsterilized

terns and (rat), 106:64Y Neuroblastoma,

metabolism,

disease and, 106:1094-srr Nonsense

106:77 1-ct

glycine cytopto-

tection and (rat), 106:168

animal model of

106:1215

inhibition,

proteolysis,

Nonoxidative

106:260-e

gastrointesti-

nal involvement in, 106:846

pancreatic, contrast medium injury and

(piglet),

lymphoma,

Nonlysosomal

106:464

Ondansetron,

lower esopha-

geal sphincter and, 106:1397-c

hepatic, getmander and (mouse), 106:285-

106:42 pancreatic carcinoma and, 106:1645

noncholinergic

Non-Hodgkin’s

Neuropathic

Oncogenes colon cancer staging and, 106:2-tmig,

neurotransmitters,

106:658

Neurones,

esophageal (opos-

C (NANB/C) hepatitis,

Nonadrenergic, and,

106:108

safety of, 106: 1400-c

oxide synthase,

terferon a! for, 106:686

action,

Neurokinin

injury and

sum), 106:1444

injury and

Necrosis

Neonates,

intestinal

(rat), 106:346

nitric oxide and (tat), 106:367

Neural

106:615 continuous infusions of, lob:60 for peptic stricture disease, 106:907

(rat), 106:346

Nectotiting

bacterial overgrowth and, 106:557-tmig,

hypoxia-induced

colonic relaxation and (dog), 106:606

tmig,

Omeprazole

gastric alkaline response and (rat), 106:367

Nitric

Natriuretic

and,

oxide

sum), 106: 1444 L-NAME hypoxia-induced

inhibition 106:875

colonic relaxation and (dog), 106:606

106:1418

ATPase,

NADPH,

Nitric

in proximal colon, 106:125

1757

Pa purinergic

receptor,

mucous glycopro-

tein secretion and (rabbit), 106:1485 p-40 antigen,

primary scletosing cholangitis

and, 106:1-tmig,

106:185

p53 gene Barrett’s adenocarcinoma and, 106: 1589 cell cycle and, 106:1708-e colon cancer staging and, 106:2-tmig, 106:42 GI cancers and, 106:1403-tmig pancreatic cancer and, 106:1645 stomach cancer and, 106:1584 Palmitic

acid, diacylglycetols

and, 106:883

Palmitoyl-linoleoylphosphatidylcholine, in cirrhosis (baboon), lO6:152

primary sclerosing

and, lO6:161

w-3 fatty acids, nutritional and. 106: 1367-vodd

pharmacology

Pancolitis,

appendectomy and, 106:125 1

Pancreas acinar tumors, intermediate 106:1326

filaments in,

SUBJECT

1758

GASTROENTEROLOGY

INDEX

Perioperative

cancer

pS3 and

Peripheral

in, 106:1645

DCC

nutrition,

blood lymphocytes,

amino acid consumption

test and,

Peripheral

106:1638,

Peristalsis,

106:1711-e

Pancreatic

secretory

(PSTI),

trypsin

inhibitor

gastritis and, 106:735

PG-APS,

vs. chronic, 106:1390-ss

Pharmacology

acute necrotizing, contrast medium injury 106-259-e

blood test for, 106:557-tmig, gallstone-induced,

106:728

of motility

106:728 tissue,

concentration

hepatic iron

Phorone,

bombardment,

in viva gene trans-

hydroxylase

(PAH)

gene therapy and,

glutathione depletion and (mouse),

106:464 egg, ursodeoxycholic acid and, lO6:1333

phase III activity and (dog),

106:152, Phospholipids,

agglutinin

(PNA),

in colon cancer,

106:117

106:257-e alcoholic liver disease and,

106:1085-srr Phosphorylation,

Pepsin

lactase, 106:1233 T-cell receptor constant p germline gene, 106:1321 Polyps,

cystic fibrosis rectal mu-

colonic

fecal occult blood testing and, 106:277-c medical therapy for, 106:285-tmig, 106:362 peanut lectin and, 106:117 Portal hypertension, vascular

and (rat), 106:l lO6-rc

Phytohemagglutinin

esophageal secretion and, l06:973 stricture

disease,

Peptide

106:73 Piercing

YY, jejeunoileal resection and (rat), 106:94

Percutaneous

gastroscopy

(PEG), LES pressure and, 106:2tmig, 106:l3 Perfusion

manometry,

Portosystemic

in erosive esophagi-

Postcapillary

liver failure due to HCV

liver-specific,

area, lymphatic microvessels

in (rat), 106:1548

factor (PAF)

E. coli enteritis and(rabbit),

106:306

anaphylaxis and (rat),

Postprandial

colonic

sponse,

metranidazole and, hypertonic

re-

in carcinoid diarrhea,

106:1184 Postreperfusion,

endothelin

1 and (rat),

106:988 Potassium

index,

in nonalcoholic cirrhosis,

106:1611 mutation,

in progressive hepatitis

B virus, 106:243-cr liver hemorrhage and,

106:1668-cr bile acid metabolism and, 106:820-c liver hemorrhage and preeclampsia and, 106: 1668-cr Premenopause,

106:1505 intestinal

injury and

(rat), 106:346 liver fat-storing

hepatic vein

Pregnancy

(rat), 106:480

hypoxia-induced

venules,

Preeclampsia,

106:125

food protein-induced platelet-activating

factor and, 106:1301 Perifollicular

colonocyte, Na+ movement across,

collaterals,

106:1271

Precore

membrane

Platelet-activating

and, 106:248-cr Pericyres,

upper endoscopy and,

incomplete septal

thrombosis and, 106:1042

vesicles, hepatic system A activity and

tis, 106:108 Pericholangitis,

injury, 106:788-srr

Plasma endoscopic

raw kidney

beans in small intestine and (rat),

medical therapy

for, 106:907

(PHA),

supply,

cirrhosis and, 106:459

cosa and, 106:890

bFGF-CS23

gastric angioarchitec-

ture in (rat), 106:702 Portal

against fibrosis and cirrhosis (baboon),

106:1533

enteral diets, in Crohn’s disease,

106:1393-ss

taurocholate and

Phosphatidylcholine

fer and, 106:1077-srr

Peptic

gas-

106:606

inclusion disease and,

106:85,

method,

106: 1080-srr and, 106:1395-br

and,

106:160 Polymeric

colonic relaxation and (dog),

deficiency,

106:771-cr

Peanut

of by

Polymorphisms

red methylcellulose

Phenylalanine

nutrition

Pavlov pouch,

liver failure due to HCV and, 106:248-cr

(rat), 106:866

mast cells in, 106:286-tmig clinical nutrition

vagal inhibition

Phenolsulfonpthalein,

and, 106:3

esophageal infections and, lO6:523-srr

106:1048,

106:1672-cr

primary sclerosing cholangitis

Na+ transport in proximal colon

Phentolamine,

Ancylostoma c&mm

microvillus

gastrointestinal,

tric emptying and (rat), 106:1568

in, 106:674

infections

Parenteral

l06:1072-cr,

gastric acid (dog), 106:1533

Phenol

hormone and,

hepatitis C virus and, 106:994,

and, lO6:l25

in test for pancreatitis,

Paraffin-embedded

corticotropin-releasing

106:271-br

lO6:521-srr lO6:557-tmig,

colon cancer staging and, 106:2-tmig,

106:1366-vodd

Pharmacotherapy,

Phenarnil,

(PCR)

106:42 (rat), 106:960

disorders, 106:1112-e

nutritional,

106:810-e

virus, esophageal infections and,

chain reaction

106:859

Phase III activity,

lipid tolerance and, 106:742,

PAP protein,

lymphatic microvessels in

in enterocolitis

pathogenesis of,

106:269-ss Papilloma

Polymerase

(rat), 106: 1548

serum amylase in, 106:557-tmig

and (rat),

106:1024 Barrett’s adenocarcinoma and, 106: 1589

Peyer’s patches,

in (rat), 106:207,

enterocytes and (rat), 106:49 hepatocyte proliferation

hypothermic cardiopulmonary bypass and,

cathepsin B in, 106:1123-ss

Particle

106:108

intestinal

106:318

acute

106:13

Polyamines

dexamethasone and (rat), 106: 3 5

Pancreatitis

percutaneous endoscopic gas-

troscopy and, 106:2-tmig,

cow’s milk allergy and,

in erosive esophagitis,

Permeability,

insulin in (rat), 106:200

106:840

in inflammatory bowel dis-

ease, 106:596 Pneumonia,

cells

106:1514

gene therapy for insufficiency of,

PNAd antigen,

and, lO6:l6O

blood mononuclear

(PBMCs),

106:488

primary

No. 6

in inflammatory bowel disease,

Platelets,

106:827-tmig,

sclerosing cholangitis

exocrine

Parasitic

clinical nutrition

and, 106:1370-vodd

mucin and, lO6:1054

Vol. 106,

cells and, 106:1301

diacylglycerols

and,

106:883 Pre-NBF,

cystic fibrosis rectal mucosa and,

106:890

June 1994

Prickle

SUBJECT INDEX

cells, ballooned, oral hairy leukopla-

Protein

kia and, 106:506-cr Primary

biliary

cirrhosis

(PBC)

Protein

and, 106: 1342-cr acid in, 106:555-c,

106:1137-tmig, Primary

sclerosing

autoantibodies

ursodeoxy-

for hepatocellular

P-selectin,

cholangitis

(PSC)

and, 106:1-tmig,

in platelet activation,

Pseudoacute

106:160,

106:160

for, 106:286-tmig,

abdominal

106:827-

states,

upper en-

mediators,

Purine

meability and, 106:35

Whipple’s

disease and,

esophageal secretion and, 106:973

106:1477

free radicals and (cat),

iodide fluorometry,

glycine cy-

hepatocyte proliferation

and (rat), lob:168

glands,

Pyloric

of (rat), 106:423

lactate-anion exchanger and (rat), 106:S59

Pytuvate,

lower esophageal sphincter and,

and, 106:735

1 and (rat), 106:988

(pig), 106:177

Retinal

pigment

lactate-anion

ion transport

Retinoids,

exchanger and (rat),

alcoholic liver disease and,

106:1093-srr Reverse

transcription,

106:1418

hepatitis C virus

and, 106:1048,

life index,

106:286,

for Crohn’s disease,

106:287-tmig

hypothermic cardiopulmonary

Rheumatoid

arthritis,

106:827-tmig,

protection

solution 106:1562

RNA,

(RIA)

assay, lactase gene

bicarbonate transport and (rabbit), interleukin

Radioimmunoassay

platelets in, 106:840

and (rat), 106:1223 Ringer’s

ion transport dysfunc-

106:1072-cr

bypass and, 106:318

mucosal hemorrhage induced by, enteritis,

congenital

106:1542

radiation-induced

106:324 and (piglet),

epithelium,

hypertrophy of, 106:1404-tmig,

L-Rhamnose,

Radiation

free radicals and (cat),

106:629

tion and (rat), 106:286-tmig,

tion and (rat), 106:324 Prostaglandins cryptosporidiosis

endothelin

to duodenal dis-

106:544-ss ion transport dysfunc-

106:1477

106:709

Ribonuclease

106:1485 radiation-induced

swallow-induced,

tmig,

106:559

Radiation,

by ileal distension (dog),

Reperfusion

antral, pancreatic secretory

106: 1397-c receptors and (rabbit),

pattern of,

rapid total patacentesis and, 106:558-

tension, 106:583

Quality-of

Ez

P2 purinergic

relaxation,

and

colonic relaxation and (dog),

106:606 Prostaglandin

Reflex

dysfunction and (rat), 106:324

acute colitis and (rat), 106:1190

106:362

contractions,

small intestine,

motor response,

Pyrilamine,

Propionate

and, 106: 1162

hepatic, heat shock gene expression and

trypsin inhibitor

toxic oil syndrome and, 106:691

Propranolol,

Rectosigmoid

Renin,

metabolites,

Pyloric

proliferation

over 24 hours, 106:982

Relaxation,

(rat), 106: 1024

colonocyte metabolism

epithelial

stress tasks, acute stress reac-

Putrescine,

106:1112-e Proline

toprotection

transfer and, 106:1078-srr Rectal

106:606

106:629

disorders and,

106:540-e in vivo gene

106:814-ss upper endoscopy and,

tions and, 106:1403-tmig,

intestinal per-

106:306,

methods,

sulindac and, 106:285-tmig,

liver, pteeclampsia and,

106:782-cr Psychological

106:691

Propidium

Receptor-mediated

106:798-srr Psoriasis,

106:42

E. co/i strain, in bacterial en-

calcium supplementation

Pseudoperforations,

106:494

acid in, 106: 134

motility

stress ul-

doscopy and, 106:798-srr

(u,), toxic oil syndrome and,

Proinflammatory

studies,

106:1668-cr

HLA DR4 and, 106:1-tmig, ursodeoxycholic

106:2-tmig, RDEC-H19A,

teritis (rabbit),

inhibitor

Pseudoaneurysms,

methotrexate

carci-

rmig, 106:840

genetics of, 106:1676-srr

Prokinesia,

signaling and, 106:763

irradiation,

cet-related bleeding and, 106:60

(PBS),

106:185

Procollagen

intracellular

106:709-tmig

ras oncogene, colon cancer staging and,

noma, 106:1032

cholic acid in, 106:134 Primary

of, 106:558,

C, cholecystokinin-coupled

Proton-pump

106:1284

biliary sclerosis

kinase

Proton

nuclear envelope proteins in, 106:193 ursodeoxycholic

Rapid total paracentesis, circulatory effects

cosa and, 106:890

genetics of, 106:1676-srr hyperthyroidism

A, cystic fibrosis rectal mu-

kinase

1 and (rat), 106:1493

hepatitis C virus, 106:248-cr,

eicosanoid production and (dog), 1O6:297

eicosanoid production and (dog), 106:297

106:106:994,

106:1048,

food protein-induced

gastrin and, 106: 1263

cr, 106:1291,

106:1344-cr,

anaphylaxis and (rat),

interleukin

1 and (rat), 106:1493 synthase,

1 and (rat), 106:1493

Radioligands,

somatostatin

food protein-in-

duced anaphylaxis and (rat), 106:1505

Radiology,

gastrointestinal,

106:1395-br

Saccbaromyces kuhrdii,

antibody,

entero-

106:28

and (prairie dog),

106:1662

Rapeseed

oil, toxic oil syndrome and,

Safflower

diffusion, into cholesterol gallstones,

(rat), 106:94

of a mutein of ba-

sic fibroblast growth factor in rats,

106:749 resection and (rat), 106:94

106:1106

Salicylates,

for ulcerative colitis,

acute pancreatitis

Rapid Communications oral administration

106:65

oil, dietary, in mucosal adaptation 106:1429

Saline

106:691 Accelerated healing of duodenal ulcers by

Protein

cholera toxin inhi-

bition by, 106:2-tmig,

Ranitidine for peptic stricture disease, 106:907

in enteric cryptosporidiosis, gallbladder contractility

538 monoclonal

cytes and (rat), 106:49

receptors and,

continuous infusions of, 106:60

Prostanoids

jejeunoileal

RPN

106:95 1

misoprostol and, 106:658 Prostaglandin

interleukin

106:1072-

106:1672-cr

hepatitis B virus and, 106:664

106:1505 gastric emptying and (rat), 106:1568

1759

(rat) and, 106:207

hepatic iron concentration ileal motility Sandhoff

and, 106:674

patterns and (rat), 106:649

disease,

diarrhea and autonomic

dysfunction in, 106:775-cr

1760

SUBJECT

Saponin,

GASTROENTEROLOGY

INDEX

cholecystokinin-coupled lular signaling

and,

Should you be following

intracel-

antigen

106:763

colon cancer?,

Satiety cholecystokinin gastrin

and,

releasing

106: 1168,

tmig, SB-conditioned

cells and,

Selectin, Sensory

lectins

in colon cancer

endoscopic

106:2-tmig,

gastroscopy

receptor,

mors,

106:1723-c

Scleroderma-like

and,

106:827-

(rabbit),

106:1208

P and (rat),

and,

toxic oil syn-

106:286,

enzyme

hepatitis

immunoassay,

C virus and,

Serine,

prob-

cholangitis

and,

inhibitor,

insulin

bowel disease and,

and (rat),

Sexual

dysfunction,

106:200

75, in cholestatic

SeHCAT

106:596

injury,

mucosal

Shiga-like

and chronic

pancreaticis:

really different?, cancer?,

are they

against

Shock, colorectal

Shock-wave

disease: no longer

reflux?,

laser therapy

duced

mucosal

106: 1714

tion?,

adaptive clinical

have we

106:544 can decrease co-

response:

food for thought,

nonpolyposis

(Lynch syndrome): linkage,

new insights B virus: passing

the

tumor-de-

rived immunosuppression, A new endoscopic

procedure

lous cholecystitis, sphincter

in-

106:1718

gallbladder:

of Oddi

pancrearitis, Role of cathepsin

Spain,

and,

106: 1123

106:803-e

Skullcap, of

SLC-44

toxic oil syndrome peptide,

Reports

Alcohol

hepatitis

B vi-

in, 106:691

expression

of (rat),

polypsosis

and,

Cellular

and subcellular

calcium

signaling

epithelium,

perforations

gestive

of the upper

di-

tract: a review of their pathoprevention,

ment,

and manage-

106:787 infections:

cation,

diagnosis,

risk factors, presenand treatment,

106:509 peptide

and (rat),

Gene therapy:

applications

to the treat-

ment ofgastrointestinal

and,

and liver dis-

eases, 106:1076

106:1150 changes

in, serum hy-

106:280-c

in liver disease,

106:285-tmig

CD1 molecule

106:1143

and Reviews

and the liver: 1994 update,

Esophageal

perfusion,

cells,

analysis, 106:664

genesis,

106: 150 1

yield of, 106:593

aluronan

106:269 B in the pathogenesis

and,

transduction

Sinusoidal

tu-

106:1349

adenomatous

E. coli and,

in endocrine

in gastrointestinal

106:1277,

106: 143

to blame?,

blotting

Spasmolytic

bowel disease,

106:1723-c

Endoscopic

atria1 natriuretic

of gallstone-induced

acute oancreatitis.

and,

106:285-tmig Signal

and,

106:1085 TIPS placement

colon cancer screening

second,

colonic

106:95 1

scintigraphy,

rus and,

Special

106:375

106:1385-e

is the

106:1716 The pathogenesis

106:1367-

acute colitis and (rat),

106:1138-tmig,

106: 17 17 provides

sight into an old disease: acute acalcuPain and an intact

and (rat), 106:559 and,

in inflammatory

receptor Southern

106:1190 stenosis,

familial

normal

106: 1242

106:336

colonoscopy

for esophageal

and,

short bowel syndrome

mors,

Sigmoidoscopy

106: 1388

A mechanism

exchanger pharmacology

current,

from

and (cat), 106:381

assay,

106:828-tmig,

of Oar), 106:423

effects of (rat),

cancer

106:815

to hepatitis

torch,

colorectal

pressure

106:1369-&d

metabolism

trophic

get to know gelsolin!,

and (rat), 106:35 lower esophageal

adhesion

analogue,

(SCFAs)

Short-circuit Shunt

genetic

106:215,

106: 1369-vodd

acids

intestinal

and (opossum),

Somatostatin

vodd

106:813 Hereditary

recur-

and (rat), 106: 1190

nutritional

106:814 Gastroenterologists:

fatty

colonocyte

106: 1391

Gastrocolonic

Immunity

Short-chain

lactate-anion

106:268

is it time for a resurrec-

B

Solid-phase

in (rat), 106:94

and,

106:558-

106:125 1 vasoactive

nitroprusside,

receptors,

hyperplasia

and,

cells,

epithelium

gallstone

and,

106:807-e

dexamethasone

Sodium

106:262

nutrition

colitis

sphincter

syndrome

acute colitis

cancer mortality,

Fundoplication:

bowel

(rab-

enterotoxin

rence and, 106:1-tmig, Short

for radiation-in-

blood testing

lorectal

prevents

hemorrhage:

seen the light?, Fecal occult

by bits

106:643,

muscle

Sodium,

106:450

lithotripsy,

106:225m

how surgery

gastroesophageal Endoscopic

feeding

106: 1393

Do we understand

staphylococcal

disease recurrence

polypeptide

106:540-e

and (mouse),

106:1121

and pieces?,

lethal,

106:94

106:866

106:1467

and,

I, in E. coli enteritis

toxin

bit), 106:306,

106: 1390

Big and tall: protective Crohn’s

disease and,

endoscopy

106:829

oil and (rat),

and (rat),

ulcerative Smooth

106:788-srr

Summaries

Acute

upper

and,

beans and (rat), 106:73 Menhaden

tmig,

106:775-cr Shearing

liver disease,

106:134 Selected

Sandhoff

isoforms

Smoking

106:973

gastric

in (rat,

and (cat), 106:629

taurocholare

blood flow and (rat), 106:440

inflammatory

A-chain

Crohn’s secretion

Bl-adducts

106:433

free radicals resection,

106:161

protease

Secretin

aflatoxin

raw kidney 106:459

sclerosing

ileus and,

106:924

lactase gene in (rat), 106:1223

lesions and

oligonucleotide

esophageal

Serine

106:1048

mucosal

incomplete,

ing, primary and,

postoperative

human),

106:1524

Sequence-specific

106:691

generation

gastric

cirrhosis,

gastroenteroparhy

106:500-cr

dysmotility,

laminin

HCI-induced Septal

hemorrhagic

enterocytes,

substance

(rat), tu-

in endocrine

lesions,

drome

and,

106:13

somatostatin

diffuse

of, 106:6 15

106:916

106:827-tmig,

in acute colitis

gastric,

106:85

activation

440

percutaneous

and,

106:840

neurons

colon,

Scintigraphy

Second

addressin,

overgrowth

cisapride and,

platelet tmig,

S&cbaromyces

106:65

analysis,

of a mucosal

No. 6

intestine

bacterial

106:1122

106:1137-

106: 1374-e

medium,

bodardii and, Scatchard

and,

Small

with

106:546

Specific regulation

106:145 1

peptide

carcinoembryonic

levels in your patients

Vol. 106,

and (rat),

Immunogenetics

of chronic

liver diseases,

106:1676 E. coli and,

Spectroflurometry,

106:1150

Spermidine endoluminal

uptake

of (rat),

106:49

June 1994

SUBJECT INDEX

hepatocyte

proliferation

and (rat),

primary

106:1024 Spermine

Stroma,

endoluminal

uptake

hepatocyte

of (rat),

proliferation

mice),

and (rat),

Subjective

and, Sphincter

bladder

dysfunction,

and,

intact gall-

choledocholithiasis sphincter

and,

of Oddi

bacteria,

infection

with (mon-

Splenic

cells,

enterotoxin SR48968,

staphylococcal

B and (mouse),

colonic

relaxation enterotoxin

jury (mouse), acid,

B, in liver in-

106:450

diacylglycerols

hepatic,

and,

alcoholic

106883

notch,

and,

endoscopic

106:2-tmig,

gas-

resection

and, nitric

and (rat),

oxide in (rat),

Swallow

polyposis

in, 106:1584 and,

(SOD),

heat shock

hemorrhagic

gastroenteropathy

System

106:500-cr

psychological

and, lesions,

endoscopic

106:2-tmig,

sensory

gastroscopy

106:13

and (cat),

disease and,

system,

and (dog),

neurons

and (rat),

pancreatic

phase III ac-

trypsin

inhibitor

and,

system,

perforation

of, 106:797-srr

phase III activity spasmolytic

106:1533

and (rat),

P and (rat),

106:336

106:286,

lO6:440

impair-

Stool Bl-adduct

human),

formation

and (rat,

106:433

man),

106:28

absorption

acute,

sphincteric

106:1403-tmig,

contraction 106:1477

and,

activation

106:840

and,

106:827-tmig,

as tumor

marker,

106:285

and the intestine,

~53 and gastrointestinal

106:827 106:557

cancers,

(rat), mem-

in inflammatory

Satiety

signals,

Serum

triglycerides,

Smoking

alcohol,

overgrowth,

is associated

with recurrent

disease,

106:558

platelets

in IBD,

p germline

gene

A TIPS is not forever,

hepa-

TNF-(Y: guilt

and (rat), 106:649 106:1493

proliferation,

and (rabbit),

cystic fibrosis

rectal mucosa

and, 106:890

106:1138

by association,

106:1404 106:558

bowel syndrome,

106:828 A unifying

hypothesis

for primary

geal dysmotilities, Variable

106:1562

106:2

106:827

tap for tense ascites,

Ursodeoxycholic

106:117 Theophylline

106:557

106:828

autoimmune

Total

and pancre-

106:558

Two types of irritable

transport

diarrhea,

colon cancer by PCR,

Sticky

Tetrodotoxin 1 and (rat),

disease,

106: 1137

Silent bacterial

Staging

106:1321

in colonic

106:827

index for Crohn’s

The real culprit

Crohn’s

106:1333

patterns

106:1403

ileus and cisapride,

A quality-of-life

atitis,

cholesterol-rich and,

constant

interleukin

in cirrhosis,

A new blood test for pancreatitis,

106:1333

polymorphisms,

bicarbonate

Strictures platelet

cholesterol-rich

and,

receptor

TF antigen,

and the kidney

Silent Budd-Chiari,

ileal motility

of Cvygtospwidium (calf, hu-

supernatant, Stress,

in calcium

titis and,

aflatoxin

gastroenteri106:3

membranes T-cell

cho-

106:1403

106:1-tmig,

Tauroursodeoxycholate,

and (dog),

peptide

substance

eosinophilic

Taurodeoxycholate, branes

sclerosing

106:286

106:286

106:866

secretory

Mucin

106:1533

hepatic

dog,

Taurocholate,

106:735

coli,

106:557

of (rat), 106:480

tis and,

106:1524

as

106:1403

for polyposis

for promary

Postoperative

A activity,

Tapeworm,

therapy

Neuropeptides

distension, percutaneous

not as simple

106:1404

A new risk factor for UC, 106:1137

nervous

ment

in cirrhosis:

Misoprostol

106:177

106:1477

loss of, Sandhoff

tivity

C: more is

106:285

and (pig),

LY267108

106:285 for hepatitis

106:558

Methotrexate

106:775-cr

106: 1398-c

colitis,

cold feet, and the gullet,

Medical

coli, (mouse),

relaxation,

Sympathetic

Helicobacterpyhi

better, it looks,

106:624 and p53

therapy

langitis,

dismutase

Sweating,

106:2

106:2

tea hepatitis,

106:362

response,

106:367 of MCCIAPC

Herbal

colitis,

in liver injury

Swallow-induced

cancer allelic deletions

link for ulcerative

Math,

stress and, response,

A genetic

Malnutrition for ulcerative

gene expression

106:1429

106:l

than a push,

yeast,

106:450

106:1455

and humans,

A friendly

lactase gene and (rat),

for familial

106:13

factor (Y and,

colitis

and,

(rat),

worms,

A drip is better

Interferon

Superantigen,

Stomach

diffuse

prodrugs

106:1223

Superoxide necrosis

alkaline

dysfunc-

106:1429

Steroids ulcerative

106:1137 Dogs,

ion transport

106:285-tmig,

percutaneous

troscopy tumor

flow and (rat), 106:440

isomahase,

106:1091-srr Sternal

blood

jejeunoileal

Sulindac,

liver disease,

106:557

Sulfasalazine,

liver disease and,

and chronic

106:1138

106:94

Staphylococcal Stearic

106:828-tmig,

in glucocorticoid

Sucrase

fuel, 106: 1137

Cryoglobulins

106:405 Sucrase,

and PSC, 106:l

mast cells, and the intestine,

Does Helicobacterpylwi cause dyspepsia?,

mucosal

Succinate,

106:450

and (dog),

106:606

Steatosis,

106:1208

tion and (rat), 106:324

mononuclear

for metronida-

106:285

and (rabbit),

radiation-induced

key), 106:1405

genes,

Chili peppers, Colonic

106:286-tmig,

gastric

mechanism

sole, 106:1138

by, 106:973

disease and,

gastric

and,

106:1716-ss Spiral

esophageal,

dysfunc-

106:324

in GASTROENTEROLOGY

Antibodies,

glands,

106:95 1

lO6:1062

dysfunction

Month

of nutrition

P

Crohn’s

Sphincterotomy

This

106:1365-vodd

acute colitis

106: 17 16-ss

ion transport

An alternative

mucous

Substance

and (nude

assessment,

secretion

106:937

radiation-induced tion and (rat),

receptors

global

status,

of Oddi

and,

106: 19

Submucosal

cell cycle, shock wave cavitation

cholangitis

106:185

fibronectin

106:49

106:1024 S-phase,

sclerosing

106:160,

1761

acid for PBC,

expression

esopha-

106:827

of familial

106:1137 polyposis,

106:1404 The woodchuck

connection,

Why gallstones

recur,

106:l

106:828

1762

SUBJECT

Threonine,

GASTROENTEROLOGY

INDEX

esophageal secretion and,

bone marrow, HBV immunity and,

106973 Thrombin,

platelet-activating

intestinal,

Thromboxane

for microvillus

inclusion dis-

ease, 106:771-cr

Bz

IL-lra

eicosanoid production and (dog), 106:297

Alagille’s syndrome and, 106: 1068-cr

indomethacin-induced

albumin mRNA in, 106:239

enteropathy and

Thymidilate

synthetase,

Thymidine

incorporation

106:285-tmig,

primary biliary cirrhosis and, 106:1138-

peanut lectin and, 106: 117

tmig, 106: 1284

method,

glutathione

and (rat),

Trefoil

peptides,

Tight

junctions,

eicosanoid production and

Tremor,

Tissue

wasting,

in nonalcoholic cirrhosis,

106:1611 T lymphocytes,

oral hairy leukoplakia and,

106:506-cr TNM classification,

prognostic factors after

hepatic resection and, 106:720 cr-Tocopherol,

toxic oil syndrome and,

106:691 Total

ascites

tap, circulatory effects of,

106:558-tmig, Toxic

in Alagille’s syndrome,

fibrosis and, 106:691

measuring esophagitis,

device,

in erosive

106:108

hepatitis B virus carriers

and, 106:lOOO incomplete septal cirrhosis and, 106:459 Transcription

factors

hepatocyte differentiation

and (rat),

106:1625 toxic oil syndrome and, 106:691 Transepithelial

electrical

resistances

dexamethasone and (rat), 106:35 eicosanoid production and (dog), 106:297 Transferrin

endocytosis,

by intestinal cells

(rat), 106:414 Transfusion,

diffuse hemorrhagic gastroen-

teropathy and, 106:500-cr Transglutaminase, Transjugular

in colitis (rat), 106:399

intrahepatic

shunt placement,

portosystemic occlusion or ste-

nosis after, 106:1138-tmig, 106:1277, Transmembrane

106:807 106:1129-c

106:1384-e

endoscopic

regulator,

bFGF-CS23

106:810-e buffer,

taurocholate and (rat), 106:866 Trimethoprim-sulfamethoxazole for Whipple’s

vesicles,

United States, precore mutation in HBV virus and, 106:243-cr Unsaturated

106:782-cr

fats, in mucosal adaptation

(rat), 106:94

prolonged, gastric emptying

Upper

digestive

and (rat), 106:1505

tract, endoscopic perfora-

tions of, 106:787-srr

for herbal tea hepatitis

Ursodeoxycholate,

(mouse), 106:464

unconjugated,

Ursodeoxycholic

amino acid consumption test and, 106:488 hydrolysis, Saccharomyca boulardii and, 106:65

acid

in cholestatic liver disease, 106:134 cholesterol-rich

membranes and, 106: 1333

in primary biliary cirrhosis, activation

pancreatitis Tumor

necrosis

peptides,

in acute

(rat), 106:207 factor (Y (TNF-ru)

inflammatory disease and, 106:1404-tmig, 106:1455

106:1137-tmig, Ussing

106:555-c,

106:1284

chambers

acute colitis and (rat), lob:1190 cryptosporidiosis

and, 106:28,

106:1418

eicosanoid production and (dog), 106:297

staphylococcal enterotoxin B and (mouse), 106:450

radiation-induced

ion transport dysfunc-

tion and (rat), 106:286-tmig,

ulcerative colitis and, 106:557-tmig, 106:637 Tumor-suppressor

choles-

terol-rich membranes and, 106: 1333

Trypsin

Trypsinogen

ursodeoxycholic acid

and, 106:1333

(TMPdisease,

and, 106:1062

liver failure due to HCV and, 106:248-cr Unilamellar

Trihydroxymethylaminomethane

Trituration,

for (rat), 106: 1106-rc

choledocholithiasis

and, 106:742,

106:324 tumot necrosis factor (Y and, 106:1514

genes

colon cancer staging and, 106:2-tmig, 106:42

Vacuuming,

in pancreatic carcinoma, 106:1645 gel electrophoresis,

Tyrosine,

anoxic injury of hepatocytes and

(rat), 106: 168

for congested blood, in hepati-

tis C virus transmission, Vagal dysfunction, Vagal inhibition,

106:1596

cisapride and, 106:916 phase III activity and

(dog), 106:1533 Vagovagal

cholecystec-

tomy, acute acalculous cholecystitis and, 106:1718-ss

pancreatitis

keratin polypeptides and, 106: 1326

conductance

Ulcers,

Ultrasonography

Saccbaromycesboulardii and, 106:65

SMX),

activity and (rat),

tumor necrosis factor (Y and, 106:1455

106:168 Triglycerides,

I-

106:399

acid

Two-dimensional

in cystic fibrosis, 106:890 Transpapillary

smoking and, 106:558-tmig, surveillance for, 106:278-c, transglutaminase

anoxic injury of hepatocytes and (rat),

Troleandomycin,

Transaminases asymptomatic

Trichloroacetic

106:709

oil syndrome,

Traction

expression of (rat),

106: 106%cr

(dog), 106:297

106:840

primary sclerosing cholangitis and, 106: tmig, 106:185

106:336

106:1199

and, 106: 1368-vodd

platelets in, 106:827-tmig,

106:506-cr

lectins in colon cancer cells and, 106:SS Tietze

oral hairy leukoplakia in, 106:506-cr parenteral nutrition

organ, oral hairy leukoplakia and,

106:362

106:637

left-sided, cyclosporine enemas for,

HLA antigens and, 106:1684-srr

familial adenomatous polypsosis and,

106:637

gene in, 106:557-tmig,

mesalamine and (rat), 106:399

106:1672-cr

shock wave cavita-

tion and, 106:937

ptodrugs for (rat), 106:405

in, lO6:557-tmig,

106:1429

hepatitis C virus and, 106:994,

(rat), 106:567

glucocortoid HLA-B27

liver

colitis and (rat), 106:399

butyrate and (rat), 106:399 factor XIII and (rat), 106:399

106:248-cr

hepatic venous, 106:828-tmig,

colitis

106:1382-e

heart, liver failure due to HCV and,

106:1042

No. 6

appendectomy and, 106:125 1,

106:1388-ss

factor and,

106:1301 Thrombosis,

Ulcerative

Transplantation

Vol. 106,

reflux,

phase III activity and

(dog), 106:1533 Ulceration,

gastric,

pancreatic secretory

trypsin inhibitor

and, 106:735

Valerate,

lactate-anion 106:559

exchanger and (rat),

June 1994

SUBJECT INDEX 1763

Valinomycin,

Na+ transport in proximal co-

pathophysiological

lon and, 106:125 Variceal

bleeding,

siderations,

incomplete septal cirrho-

Vincristine

sis and, 106:459 Varicella

zoster virus (VZV), changes,

esophageal

Wheat

Viral vectors, Visual

and, 106:500-cr

esophageal infections and,

intestinal

polypeptide

(VIP)

Visual

inhibition

function,

Whipple’s

Vitamin

sphincter and

Vitamin

106:875 (opossum), 106: 1467

blood cells, Sandhoff disease and,

White

matter,

scales,

satiety effects of

Whole-body

and, 106: 145 I

radiation-induced

Whipple’s

disease and,

Wooden

Xanthine

John

H., 106: 1139-aga

receptors in,

106:951

Vibtio cbohue, mucosal barrier and, 106:257-e

Weakening

injury,

upper endoscopy and,

fentanyl in,

free radicals and (cat),

colon cancer risk and, 106:1121-ss

Western

blotting

hqdostoma

106: 1365

inflammation:

glutamine

alcoholic liver disease and,

106:1093-srr Xylose bacterial overgrowth and, 106:557-tmig, 106:615

Weight,

hypothermic cardiopulmonary bypass and, 106:318

analysis

caninum and, 106: 1 -tmig, Yeast,

106:) Diseases

Advances in clinical nutrition, Cytokines in intestinal

oxidase,

Xenobiotics,

106:789-srr

on Digestive

chest phenomenon,

cells, eicosanoid produc-

sopressin response to, 106:678 K+ channels and

(rat), 106:1016

ViewPoints

hepa-

106:820-c

Water load, in cirrhosis, plasma arginine va-

tmig, 106:709

106:828-tmig,

virus (WHV),

titis B virus and, 106:828-tmig, 106:1006

E, alcoholic liver disease and,

tion by (dog), 106:297 Walsh,

rapid total paracentesis and, 106:558-

somatostatin

ion transport dys-

106:629

Vasodilation

intestinal,

disease

106:324

tion and (rat), 106:324

vascular ATP-sensitive

irradiation,

Wood chuck hepatitis

A, alcoholic liver disease and,

VNCC epithelial

ion transport dysfunc-

cerebral, Whipple’s

function and (rat), 106:286-tmig,

106:1095-srr

IgA production and, 106:576

central nervous system

White

106:1085-srr

gene, gastroesophageal

disease,

and, 106:782-cr

106:782-cr

and, 106:827-tmig,

in colon

106:775-cr

in vivo gene transfer and,

analogue

(WGA),

and, 106:782-cr

cholecystokinin

achalasia and, 106: 1397-c

Veins,

germ agglutinin

cancer cell growth, 106:85

106:1078-srr

diffnse hemorrhagic gas-

troenteropathy

deglutitive

crypt cell proliferation

106:5 16-srr in inflammatory

and,

106:883

HLA antigens and,

Viral infections,

bowel disease, 106:596

Vasoactive

bran, dietary, diacylglycerols

106: 1684-srr

E. coli enteritis and (rab-

endothelium,

Vasculopathy,

arrest,

Viral hepatitis,

bit), 106:306 Vascular

Wheat

and, 106:117

infections and, 106:520-srr Vascular

and clinical con-

106:533

mucin and, 106:353 spasmolytic peptide and (rat), 106:336

cholera toxin inhibition 106:2-tmig,

synthetase and. 106: 13 12 Yersinia

by-tmig,

106:65

enterocolitica, (rat), 106:1190

acute colitis and